t1702887-10q - none

0001571049-17-008421.txt : 20171106 0001571049-17-008421.hdr.sgml : 20171106 20171106160632 ACCESSION NUMBER: 0001571049-17-008421 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 59 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171106 DATE AS OF CHANGE: 20171106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP CENTRAL INDEX KEY: 0001069899 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 131840497 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36410 FILM NUMBER: 171179559 BUSINESS ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 BUSINESS PHONE: 201-329-7300 MAIL ADDRESS: STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR STREET 2: 300 FRANK W. BURR BLVD., SUITE 21 CITY: TEANECK STATE: NJ ZIP: 07666 FORMER COMPANY: FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC DATE OF NAME CHANGE: 19980908 10-Q 1 t1702887-10q.htm FORM 10-Q t1702887-10q - none - 2.622171s

TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2017

☐

TRANSITION REPORT PURSUANT TO SECTION 13 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 001-36410

Phibro Animal Health Corporation

(Exact name of registrant as specified in its charter)

	Delaware			13-1840497
	(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)

Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21
Teaneck, New Jersey

(Address of Principal Executive Offices)

07666-6712

(Zip Code)

(201) 329-7300

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.) Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☐

Accelerated filer

☒

Non-accelerated filer

☐

(Do not check if a smaller reporting company)

Smaller reporting company

☐

Emerging growth company

☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of October 30, 2017, there were 19,581,889 shares of the registrant’s Class A common stock, par value $0.0001 per share, and 20,602,836 shares of the registrant’s Class B common stock, par value $0.0001 per share, outstanding.

TABLE OF CONTENTS

PHIBRO ANIMAL HEALTH CORPORATION

TABLE OF CONTENTS

	Page
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)		3
Consolidated Statements of Operations		3
Consolidated Statements of Comprehensive Income		4
Consolidated Balance Sheets		5
Consolidated Statements of Cash Flows		6
Notes to Consolidated Financial Statements		7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
Item 3. Quantitative and Qualitative Disclosures About Market Risk		26
Item 4. Controls and Procedures		27
PART II—OTHER INFORMATION
Item 1. Legal Proceedings		28
Item 1A. Risk Factors		28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		28
Item 3. Defaults Upon Senior Securities		28
Item 4. Mine Safety Disclosures		28
Item 5. Other Information		28
Item 6. Exhibits		28
SIGNATURES		29

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months
For the Periods Ended September 30	2017			2016
	(unaudited) (in thousands, except per share amounts)
Net sales		$	193,412		$	187,987
Cost of goods sold			130,030			126,988
Gross profit			63,382			60,999
Selling, general and administrative expenses			40,995			39,186
Operating income			22,387			21,813
Interest expense, net			3,118			3,907
Foreign currency (gains) losses, net			325			334
Income before income taxes			18,944			17,572
Provision (benefit) for income taxes			3,052			5,395
Net income		$	15,892		$	12,177
Net income per share
basic		$	0.40		$	0.31
diluted		$	0.39		$	0.31
Weighted average common shares outstanding
basic			39,944			39,408
diluted			40,293			39,906
Dividends per share		$	0.10		$	0.10

The accompanying notes are an integral part of these consolidated financial statements

TABLE OF CONTENTS

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

	Three Months
For the Periods Ended September 30	2017			2016
	(unaudited) (in thousands)
Net income		$	15,892		$	12,177
Change in fair value of derivative instruments			(622)			34
Foreign currency translation adjustment			3,233			(893)
Unrecognized net pension gains (losses)			131			7,169
(Provision) benefit for income taxes			187			(2,750)
Other comprehensive income (loss)			2,929			3,560
Comprehensive income		$	18,821		$	15,737

The accompanying notes are an integral part of these consolidated financial statements

TABLE OF CONTENTS

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

As of	September 30, 2017			June 30, 2017
	(unaudited) (in thousands, except share and per share amounts)
ASSETS
Cash and cash equivalents		$	62,097		$	56,083
Accounts receivable, net			136,337			125,847
Inventories, net			170,928			161,233
Other current assets			25,193			20,502
Total current assets			394,555			363,665
Property, plant and equipment, net			131,242			127,351
Intangibles, net			64,457			54,602
Goodwill			23,982			23,982
Other assets			56,875			53,797
Total assets		$	671,111		$	623,397
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt		$	7,895		$	6,250
Accounts payable			61,732			56,894
Accrued expenses and other current liabilities			51,480			52,652
Total current liabilities			121,107			115,796
Revolving credit facility			85,000			65,000
Long-term debt			238,959			241,891
Other liabilities			56,570			49,553
Total liabilities			501,636			472,240
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 19,555,839 and 19,249,132 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively; 30,000,000 Class B shares authorized, 20,614,836 and 20,626,836 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively			4			4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding			—			—
Paid-in capital			127,326			123,840
Retained earnings			94,653			82,750
Accumulated other comprehensive income (loss)			(52,508)			(55,437)
Total stockholders’ equity			169,475			151,157
Total liabilities and stockholders’ equity		$	671,111		$	623,397

The accompanying notes are an integral part of these consolidated financial statements

TABLE OF CONTENTS

PHIBRO ANIMAL HEALTH CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Three Months
For the Periods Ended September 30	2017			2016
	(unaudited) (in thousands)
OPERATING ACTIVITIES
Net income		$	15,892		$	12,177
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization			6,644			6,318
Amortization of debt issuance costs and debt discount			221			253
Acquisition-related cost of goods sold			249			—
Acquisition-related accrued compensation			437			420
Acquisition-related accrued interest			253			393
Deferred income taxes			770			1,706
Foreign currency (gains) losses, net			345			97
Other			213			87
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable, net			(8,386)			3,906
Inventories, net			(5,196)			4,544
Other current assets			(4,458)			(2,430)
Other assets			332			346
Accounts payable			3,652			(5,004)
Accrued expenses and other liabilities			(6,165)			(1,357)
Net cash provided (used) by operating activities			4,803			21,456
INVESTING ACTIVITIES
Capital expenditures			(4,998)			(5,911)
Business acquisition			(11,562)			—
Other, net			(272)			25
Net cash provided (used) by investing activities			(16,832)			(5,886)
FINANCING ACTIVITIES
Revolving credit facility borrowings			61,870			34,000
Revolving credit facility repayments			(41,870)			(41,000)
Payments of long-term debt, capital leases and other			(1,652)			(729)
Proceeds from common shares issued			3,486			—
Dividends paid			(3,989)			(3,941)
Net cash provided (used) by financing activities			17,845			(11,670)
Effect of exchange rate changes on cash			198			(90)
Net increase (decrease) in cash and cash equivalents			6,014			3,810
Cash and cash equivalents at beginning of period			56,083			33,605
Cash and cash equivalents at end of period		$	62,097		$	37,415

The accompanying notes are an integral part of these consolidated financial statements

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except per share amounts)
(unaudited)

Description of Business

Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.

The unaudited consolidated financial information for the three months ended September 30, 2017 and 2016, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017 (the “Annual Report”), filed with the Securities and Exchange Commission on August 30, 2017 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2017, was derived from the audited consolidated financial statements, which include the accounts of Phibro and its consolidated subsidiaries, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.

The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated in the consolidated financial statements. The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

Summary of Significant Accounting Policies and New Accounting Standards

Our significant accounting policies are described in the notes to the consolidated financial statements included in our Annual Report. As of September 30, 2017, there have been no material changes to any of the significant accounting policies contained therein.

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.

Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed exercise of stock options. For the three months ended September 30, 2017 and 2016, all common share equivalents were included in the calculation of diluted net income per share.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

	Three Months
For the Periods Ended September 30	2017			2016
Net income		$	15,892		$	12,177
Weighted average number of shares – basic			39,944			39,408
Dilutive effect of stock options			349			498
Weighted average number of shares – diluted			40,293			39,906
Net income per share
basic		$	0.40		$	0.31
diluted		$	0.39		$	0.31

Dividends

We declared and paid quarterly cash dividends of $0.10 per share, totaling $3,989 during the three months ended September 30, 2017, to holders of our Class A common stock and Class B common stock.

New Accounting Standards

Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities simplifies the application of hedge accounting guidance and improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. During the three months ended September 30, 2017, we elected early adoption of this guidance and applied the qualitative method, and it did not have a material effect on our consolidated financial statements. For additional details, see “—Derivatives.”

ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.

ASU 2016-02, Leases (Topic 842), supersedes the current lease accounting guidance, requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December 15, 2018. We are evaluating the effect of adoption of this guidance on our consolidated financial statements.

ASU 2015-11, Inventory (Topic 330), requires entities to measure inventory at the lower of cost and net realizable value (“NRV”). NRV is defined as “the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” We applied this guidance during the three months ended September 30, 2017, and it did not have a material effect on our consolidated financial statements.

ASU 2014-09, Revenue from Contracts with Customers (Topic 606), establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2014-09 and its amendments are effective for our consolidated financial statements beginning July 1, 2018. We expect to apply the new standard using the modified retrospective method. We continue to evaluate the effect that the adoption of this guidance may have on our consolidated financial statements.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

Statements of Operations—Additional Information

	Three Months
For the Periods Ended September 30	2017			2016
Interest expense, net
Term loan		$	2,033		$	2,905
Revolving credit facility			681			955
Amortization of debt issuance costs and debt discount			221			253
Acquisition-related accrued interest			253			393
Other			239			81
Interest expense			3,427			4,587
Interest (income)			(309)			(680)
		$	3,118		$	3,907
Depreciation and amortization
Depreciation of property, plant and equipment		$	5,183		$	4,731
Amortization of intangible assets			1,449			1,528
Amortization of other assets			12			59
		$	6,644		$	6,318

Balance Sheets—Additional Information

As of	September 30, 2017			June 30, 2017
Inventories
Raw materials		$	57,719		$	54,861
Work-in-process			12,014			12,402
Finished goods			101,195			93,970
		$	170,928		$	161,233

In September 2017, we acquired a business for approximately $15,000, including approximately $3,500 paid subsequent to September 30, 2017. The business develops, manufactures and markets animal health products. We accounted for the acquisition as a business combination in accordance with ASC 805, Business Combinations. Pro forma information giving effect to the acquisition has not been provided because the results are not material to the consolidated financial statements. Net assets acquired included accounts receivable, inventories, property, plant and equipment, intangible assets, accounts payable and accrued expenses. We expect to refine the valuation of certain assets and liabilities during the measurement period. The business is included in the Animal Health segment.

Goodwill balances did not change during the three months ended September 30, 2017.

We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $3,802 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

As of	September 30, 2017			June 30, 2017
Accrued expenses and other current liabilities
Employee related		$	21,030		$	26,553
Commissions and rebates			4,964			6,443
Insurance related			1,522			1,515
Professional fees			3,513			3,823
Income and other taxes			3,631			3,035
Other			16,820			11,283
		$	51,480		$	52,652

As of	September 30, 2017			June 30, 2017
Accumulated other comprehensive income (loss)
Derivative instruments		$	2,064		$	2,686
Foreign currency translation adjustment			(40,323)			(43,556)
Unrecognized net pension gains (losses)			(17,928)			(18,059)
(Provision) benefit for income taxes on derivative instruments			(1,316)			(1,553)
(Provision) benefit for incomes taxes on long-term intercompany investments			8,166			8,166
(Provision) benefit for income taxes on pension gains (losses)			(3,171)			(3,121)
		$	(52,508)		$	(55,437)

Debt

Term Loans and Revolving Credit Facilities

Pursuant to a credit agreement (the “Credit Agreement”), we have a revolving credit facility (the “Revolver”), where we can borrow up to $250,000, subject to the terms of the agreement, and a term A loan with an aggregate initial principal amount of $250,000 (the “Term A Loan,” and together with the Revolver, the “Credit Facilities”). The Credit Facilities have applicable margins equal to 2.00%, 1.75% or 1.50%, in the case of LIBOR and Eurodollar rate loans and 1.00%, 0.75% or 0.50%, in the case of base rate loans; the applicable margins are based on the First Lien Net Leverage Ratio. The libor rate is subject to a floor of 0.00%.

The Credit Facilities require, among other things, the maintenance of (i) a maximum consolidated first lien net debt to consolidated EBITDA leverage ratio and (ii) a minimum consolidated interest coverage ratio, each calculated on a trailing four quarter basis, and contain an acceleration clause should an event of default (as defined in the agreement governing the Credit Facilities) occur. As of September 30, 2017, we were in compliance with the covenants of the Credit Facilities. The Credit Facilities mature on June 29, 2022.

As of September 30, 2017, we had $85,000 in borrowings under the Revolver and had outstanding letters of credit of $4,651, leaving $160,349 available for borrowings and letters of credit under the Revolver. We obtain letters of credit in connection with certain regulatory and insurance obligations, inventory purchases and other contractual obligations. The terms of these letters of credit are one year or less.

The weighted-average interest rates for the Revolver and Term A Loan were 2.98% and 3.22%, respectively, for the three months ended September 30, 2017.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

of debt, to a fixed interest rate of 1.8325% plus the applicable rate. The agreement matures concurrent with the Credit Agreement. The interest rate swap has been designated as a highly effective cash flow hedge. For additional details, see “—Derivatives.”

Long-Term Debt

As of	September 30, 2017			June 30, 2017
Term A Loan due June 2022		$	248,438		$	250,000
Capitalized lease obligations			182			—
			248,620			250,000
Unamortized debt issuance costs and debt discount			(1,766)			(1,859)
			246,854			248,141
Less: current maturities			(7,895)			(6,250)
		$	238,959		$	241,891

Related Party Transactions

Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to us as employees or consultants and received aggregate compensation and benefits of approximately $720 and $603 during the three months ended September 30, 2017 and 2016. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

Employee Benefit Plans

The Company maintains a noncontributory defined benefit pension plan for all domestic nonunion employees employed on or prior to December 31, 2013, who meet certain requirements of age, length of service and hours worked per year. Plan benefits are based upon years of service and average compensation, as defined.

In July 2016, we amended the domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of $6,822 in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities.

Commitments and Contingencies

Environmental

Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the time period during which such costs are likely to be incurred are difficult to predict.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance.

The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based upon our experience to date, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of a facility in Santa Fe Springs, California, operated by our subsidiary Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that groundwater contamination at its site is due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, a nearby property owner has filed a complaint in the Superior Court of the State of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for alleged contamination of groundwater underneath its property, and a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling has filed a complaint under CERCLA, RCRA and the common law public nuisance doctrine in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume.

Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be approximately $6,898 and $7,211 at September 30, 2017, and June 30, 2017, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries is liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible.

Claims and Litigation

PAHC and its subsidiaries are party to a number of claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

Derivatives

We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in accumulated other comprehensive income (loss).

We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “—Fair Value Measurements.”

The following tables detail the Company’s outstanding derivatives that are designated and effective as cash flow hedges as of September 30, 2017:

Instrument

Hedge

Notional
Amount at
September 30,
2017

Fair value as of

Consolidated
Balance Sheet

September 30,
2017

June 30,
2017

Options

Brazilian Real calls

R$19,500

Other current assets

1,781

2,686

Swap

Interest rate swap

$ 150,000

Other assets

283

—

Instrument	Hedge	Gain (loss) recorded in OCI						Gain (loss) recognized in consolidated statements of operations							Consolidated Statement of Operations Line Item Total
Instrument	Hedge	September 30, 2017			September 30, 2016			Consolidated Statement of Operations	September 30, 2017			September 30, 2016			September 30, 2017			September 30, 2016
Options	Brazilian Real calls		$	(905)		$	34	Cost of goods sold		$	186		$	(1,135)		$	130,030		$	126,988
Swap	Interest rate swap		$	283		$	—	Interest expense, net		$	—		$	—		$	3,118		$	3,907

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

contracts were recorded as a component of inventory. We anticipate these gains will be recognized as an offset to cost of goods sold within the next twelve months. At June 30, 2017, net realized gains of $966 related to matured contracts were recorded as a component of inventory. We recognized $186 of these gains in cost of goods sold during the three months September 30, 2017, and anticipate we will recognize the remaining $780 of these gains in costs of goods sold in the next six months. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold.

In July 2017, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converts the floating LIBOR or base rate portion of our interest obligation on that amount of debt, to a fixed interest rate of 1.8325% plus the applicable rate. The agreement matures concurrent with the Credit Agreement. The forecasted transactions are probable of occurring, and the interest rate swap has been designated as a highly effective cash flow hedge. The fair value of the interest rate swap agreement is recorded as an asset or liability with a corresponding amount included in accumulated other comprehensive income (loss).

10.

Fair Value Measurements

Contingent Consideration on Acquisitions

We determine the fair value of contingent consideration on acquisitions based on contractual terms, our current forecast of performance factors related to the acquired business and an applicable discount rate.

Derivatives

We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates, and interest rate curves.

Fair Value of Assets (Liabilities)

As of	September 30, 2017									June 30, 2017
	Level 1			Level 2			Level 3			Level 1			Level 2			Level 3
Derivatives asset		$	—		$	1,781		$	—		$	—		$	2,686		$	—
Interest rate swap		$	—		$	283		$	—		$	—		$	—		$	—
Contingent consideration on acquisitions		$	—		$	—		$	(7,827)		$	—		$	—		$	(7,644)

The table below provides a summary of the changes in the fair value of Level 3 assets (liabilities):

Balance, June 30, 2017	$	(7,644)
Acquisition-related accrued interest		(253)
Payment		70
Balance, September 30, 2017	$	(7,827)

11.

Business Segments

The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace minerals for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. Corporate assets include cash and cash equivalents, certain debt issue costs, income tax related assets and certain other assets.

We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.

The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

	Three Months
For the Periods Ended September 30	2017			2016
Net sales
MFAs and other		$	79,603		$	83,419
Nutritional Specialties			30,777			26,304
Vaccines			18,461			14,778
Animal Health			128,841			124,501
Mineral Nutrition			52,073			51,592
Performance Products			12,498			11,894
Total segments		$	193,412		$	187,987
Depreciation and amortization
Animal Health		$	5,254		$	4,898
Mineral Nutrition			585			542
Performance Products			246			218
Total segments		$	6,085		$	5,658
Adjusted EBITDA
Animal Health		$	33,742		$	32,619
Mineral Nutrition			3,716			3,988
Performance Products			248			742
Total segments		$	37,706		$	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes		$	18,944		$	17,572
Interest expense, net			3,118			3,907
Depreciation and amortization – Total segments			6,085			5,658
Depreciation and amortization – Corporate			559			660
Corporate costs			7,589			7,524
Acquisition-related cost of goods sold			249			—
Acquisition-related accrued compensation			437			420
Acquisition-related transaction costs			400			1,274
Foreign currency (gains) losses, net			325			334
Adjusted EBITDA – Total segments		$	37,706		$	37,349

TABLE OF CONTENTS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

As of	September 30, 2017			June 30, 2017
Identifiable assets
Animal Health		$	479,075		$	442,521
Mineral Nutrition			60,371			55,184
Performance Products			22,331			23,681
Total segments			561,777			521,386
Corporate			109,334			102,011
Total		$	671,111		$	623,397

The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of $3,802 and $3,719 as of September 30, 2017 and June 30, 2017, respectively. The Performance Products segment includes an investment in equity method investee of $559 and $516 as of September 30, 2017 and June 30, 2017, respectively. Corporate assets include cash and cash equivalents, certain debt issuance costs, income tax related assets and certain other assets.

TABLE OF CONTENTS

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

Our management’s discussion and analysis of financial condition and results of operations (“MD&A”) is provided to assist readers in understanding our performance, as reflected in the results of our operations, our financial condition and our cash flows. The following discussion summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity and cash flows as of and for the periods presented below. This MD&A should be read in conjunction with our consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Our future results could differ materially from our historical performance as a result of various factors such as those discussed in “Risk Factors” and “Forward-Looking Statements.”

Overview of our business

Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. We develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. Our products help prevent, control and treat diseases, enhance nutrition to help improve health and performance and contribute to balanced mineral nutrition. We also manufacture and market specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries.

Trends and uncertainties

Our business depends heavily on a healthy and growing livestock industry. Some in the public perceive risks to human health related to the consumption of food derived from animals that utilize certain of our products, including certain of our MFA products. In particular, there is increased focus, primarily in the United States, on the use of medically important antimicrobials, as defined by the FDA. Medically important antimicrobials (“MIAs”) include classes that are prescribed in animal and human health and are listed in the Appendix of the FDA-CVM Guidance for Industry (GFI) 152. Our products that contain virginiamycin, oxytetracycline or neomycin have previously been classified by the FDA as medically important antimicrobials. This may lead to a decline in the demand for and production of food products derived from animals that utilize our MIA products and, in turn, demand for our MIA products. Livestock producers may experience decreased demand for their products or reputational harm as a result of evolving consumer views of nutrition and health-related concerns, animal rights, and other concerns. Any reputational harm to the livestock industry may also extend to companies in related industries, including us. In addition, campaigns by interest groups, activists and others with respect to perceived risks associated with the use of our products in animals, including position statements by livestock producers and their customers based on non-use of certain medicated products in livestock production, whether or not scientifically-supported, could affect public perceptions and reduce the use of our products. Those adverse consumer views related to the use of one or more of our products in animals could have a material adverse effect on our financial condition and results of operations.

Our sales in the United States of products classified by the FDA as medically important antimicrobials were approximately $18 million and $23 million for the twelve months ended September 30, 2017 and June 30, 2017, respectively.

Our business is subject to product registration and authorization regulations. Changes in the regulations could have a material impact on our business. In April 2016, the FDA began initial steps to withdraw approval of Mecadox (carbadox), due to concerns that certain residues from the product may persist in tissues for longer than previously determined. This initial action by the FDA does not prohibit the sale or use of Mecadox in the United States. In July 2016, we submitted our data, analyses and information to the FDA that we believe support the continued safe use of Mecadox. The timing of the FDA’s response to our submission is not subject to a predetermined deadline. Should we be unable to successfully defend the safety of the product, the loss of Mecadox sales would have a negative effect on the results of our operations.

Our sales in the United States of Mecadox were approximately $14 million for each of the twelve months ended September 30, 2017 and June 30, 2017, respectively.

TABLE OF CONTENTS

Analysis of the consolidated statements of operations

Summary Results of Operations

	Three Months
For the Periods Ended September 30	2017			2016			Change
	(in thousands, except per share amounts and percentages)
Net sales		$	193,412		$	187,987		$	5,425	3%
Gross profit			63,382			60,999			2,383	4%
Selling, general and administrative expenses			40,995			39,186			1,809	5%
Operating income			22,387			21,813			574	3%
Interest expense, net			3,118			3,907			(789)	(20)%
Foreign currency (gains) losses, net			325			334			(9)	(3)%
Income before income taxes			18,944			17,572			1,372	8%
Provision (benefit) for income taxes			3,052			5,395			(2,343)	(43)%
Net income		$	15,892		$	12,177		$	3,715	31%
Net income per share
basic		$	0.40		$	0.31		$	0.09
diluted		$	0.39		$	0.31		$	0.08
Weighted average number of shares outstanding
basic			39,944			39,408
diluted			40,293			39,906
Ratio to net sales
Gross profit			32.8%			32.4%
Selling, general and administrative expenses			21.2%			20.8%
Operating income			11.6%			11.6%
Income before income taxes			9.8%			9.3%
Net income			8.2%			6.5%
Effective tax rate			16.1%			30.7%

Certain amounts and percentages may reflect rounding adjustments.

Net sales, Adjusted EBITDA and reconciliation of GAAP net income to Adjusted EBITDA

We report Net sales and Adjusted EBITDA by segment to understand the operating performance of each segment. This enables us to monitor changes in net sales, costs and other actionable operating metrics at the segment level. See “—General description of non-GAAP financial measures” for descriptions of EBITDA and Adjusted EBITDA.

TABLE OF CONTENTS

Segment net sales and Adjusted EBITDA:

	Three Months
For the Periods Ended September 30	2017			2016			Change
	(in thousands, except percentages)
Net sales
MFAs and other		$	79,603		$	83,419		$	(3,816)	(5)%
Nutritional specialties			30,777			26,304			4,473	17%
Vaccines			18,461			14,778			3,683	25%
Animal Health			128,841			124,501			4,340	3%
Mineral Nutrition			52,073			51,592			481	1%
Performance Products			12,498			11,894			604	5%
Total		$	193,412		$	187,987		$	5,425	3%
Adjusted EBITDA
Animal Health		$	33,742		$	32,619		$	1,123	3%
Mineral Nutrition			3,716			3,988			(272)	(7)%
Performance Products			248			742			(494)	(67)%
Corporate			(7,589)			(7,524)			(65)	*
Total		$	30,117		$	29,825		$	292	1%
Adjusted EBITDA ratio to segment net sales
Animal Health			26.2%			26.2%
Mineral Nutrition			7.1%			7.7%
Performance Products			2.0%			6.2%
Corporate(1)			(3.9)%			(4.0)%
Total(1)			15.6%			15.9%

(1)

reflects ratio to total net sales

The table below sets forth a reconciliation of net income, as reported under GAAP, to Adjusted EBITDA:

	Three Months
For the Periods Ended September 30	2017			2016			Change
	(in thousands, except percentages)
Net income		$	15,892		$	12,177		$	3,715	31%
Interest expense, net			3,118			3,907			(789)	(20)%
Provision (benefit) for income taxes			3,052			5,395			(2,343)	(43)%
Depreciation and amortization			6,644			6,318			326	5%
EBITDA			28,706			27,797			909	3%
Acquisition-related cost of goods sold			249			—			249	*
Acquisition-related accrued compensation			437			420			17	4%
Acquisition-related transaction costs			400			1,274			(874)	(69)%
Foreign currency (gains) losses, net			325			334			(9)	(3)%
Adjusted EBITDA		$	30,117		$	29,825		$	292	1%

Certain amounts and percentages may reflect rounding adjustments.

Calculation not meaningful

TABLE OF CONTENTS

Comparison of three months ended September 30, 2017 and 2016

Net sales

Net sales of $193.4 million for the three months ended September 30, 2017, increased $5.4 million, or 3%, as compared to the three months ended September 30, 2016. Animal Health, Performance Products and Mineral Nutrition grew $4.3 million, $0.6 million and $0.5 million respectively.

Animal Health

Net sales of $128.8 million for the three months ended September 30, 2017, grew $4.3 million, or 3%. The growth was primarily due to volume increases in the nutritional specialty and vaccine product groups within the segment. Nutritional specialty products grew $4.5 million, or 17%, primarily due to volume growth of our products for the U.S. poultry and dairy industries. Vaccines grew $3.7 million, or 25%, primarily due to volume growth of our products for the poultry and swine industries. MFAs and other declined $3.8 million, or 5%, primarily due to volume declines. Domestic net sales of MFAs and other declined $10.5 million due to $4.2 million lower sales of medically important antimicrobials and due to unfavorable timing of certain customer orders. International net sales increased $6.7 million due to growth across most regions, including the benefit of improved economic conditions in Brazil.

Mineral Nutrition

Net sales of $52.1 million increased $0.5 million, or 1%, for the three months ended September 30, 2017. The increased revenue was primarily due to higher average selling prices resulting from underlying raw material commodity price increases. The increase in average selling prices was partially offset by lower volumes of trace mineral products due to customer demand.

Performance Products

Net sales of $12.5 million increased $0.6 million, or 5%, for the three months ended September 30, 2017, due to higher average selling prices and higher volumes of copper-based products.

Gross profit

Gross profit of $63.4 million for the three month ended September 30, 2017, increased $2.4 million, or 4%, as compared to the three months ended September 30, 2016. Gross profit increased to 32.8% of net sales for the three months ended September 30, 2017, as compared to 32.4% for the three months ended September 30, 2016. The three months ended September 30, 2017, included $0.2 million of acquisition-related cost of goods sold. Depreciation expense included in cost of goods sold increased $0.5 million due to recent capital expenditures. Excluding the effects of the acquisition-related cost of goods sold and increased depreciation, Animal Health gross profit increased $3.7 million due to volume growth in nutritional specialty and vaccine products, as well as lower unit costs from improved operating efficiencies, partially offset by volume declines in MFAs and other products. Mineral Nutrition gross profit decreased $0.2 million due to higher raw material costs, partially offset by higher average selling prices. Performance Products gross profit decreased $0.4 million due to higher product costs for copper-based products, partially offset by higher average selling prices of copper-based products.

Selling, general and administrative expenses

SG&A of $41.0 million for the three months ended September 30, 2017, increased $1.8 million, or 5%, as compared to the three months ended September 30, 2016. SG&A for the three months ended September 30, 2017 and 2016, included $0.4 million and $1.3 million, in acquisition-related transaction costs, respectively. Excluding these costs, SG&A increased $2.7 million, or 7%, for the year.

Animal Health SG&A increased $2.5 million, driven by sales force expansion and product development costs. Mineral Nutrition and Performance increased $0.1 million and $0.2 million, respectively. Excluding the acquisition-related transaction costs, Corporate decreased less than $0.1 million, as reduced pension costs offset increases in other expenses.

TABLE OF CONTENTS

Interest expense, net

Interest expense, net of $3.1 million for the three months ended September 30, 2017, decreased $0.8 million, or 20%, as compared to the three months ended September 30, 2016. Interest expense decreased $1.2 million compared to the prior year, primarily due to lower interest rates in the new Credit Facilities completed in June 2017. Interest income decreased $0.4 million due to less interest on deposits in foreign jurisdictions.

Foreign currency (gains) losses, net

Foreign currency (gains) losses, net for the three months ended September 30, 2017, amounted to net losses of $0.3 million, as compared to $0.3 million in net losses for the three months ended September 30, 2016. Foreign currency losses in the three months ended September 30, 2017, were primarily due to the movement of the South African and Mexican currencies relative to the U.S. dollar. Foreign currency gains and losses primarily arise from intercompany balances.

Provision (benefit) for income taxes

The provision for income taxes was $3.1 million and $5.4 million for the three months ended September 30, 2017 and 2016, respectively. The effective income tax rates for these periods were 16.1% and 30.7%, respectively. The provisions for income taxes for the three months ended September 30, 2017 included a benefit of $2.7 million from the exercise of employee stock options. Without the benefit, the effective income tax rates for the three months ended September 30, 2017 would have been 30.6%.

Net income

Net income of $15.9 million for the three months ended September 30, 2017, increased $3.7 million, as compared to net income of $12.2 million for the three months ended September 30, 2016. The increase was a result of the factors described above, including a $2.3 million reduction in income tax expense and a $0.8 million reduction in interest expense, net.

Adjusted EBITDA

Adjusted EBITDA of $30.1 million for the three months ended September 30, 2017, increased $0.3 million, or 1%, as compared to the three months ended September 30, 2016. Animal Health Adjusted EBITDA increased $1.1 million, or 3%, due to sales growth and increased gross profit, partially offset by increased SG&A. Mineral Nutrition Adjusted EBITDA decreased $0.3 million, or 7%, due to higher raw material costs, partially offset by higher average selling prices. Performance Products Adjusted EBITDA decreased $0.5 million, due to higher product costs, partially offset by higher average selling prices. Corporate expenses increased $0.1 million due to increased compensation and benefit costs, partially offset by lower pension costs.

Pension Plan and Retirement Savings Plan Changes

In July 2016, we amended our domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of $6.8 million in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities. We also modified the 401(k) retirement savings plan effective October 1, 2016, to include, for all domestic employees, a non-elective Company contribution of 3% of compensation and an additional discretionary contribution of up to 4% of compensation, depending on the employee’s age and years of service.

TABLE OF CONTENTS

Analysis of financial condition, liquidity and capital resources

Net increase (decrease) in cash and cash equivalents was:

	Three Months
For the Periods Ended September 30	2017			2016			Change
	(in thousands)
Cash provided by/(used in):
Operating activities		$	4,803		$	21,456		$	(16,653)
Investing activities			(16,832)			(5,886)			(10,946)
Financing activities			17,845			(11,670)			29,515
Effect of exchange-rate changes on cash and cash equivalents			198			(90)			288
Net increase/(decrease) in cash and cash equivalents		$	6,014		$	3,810		$	2,204

Net cash provided (used) by operating activities was comprised of:

	Three Months
For the Periods Ended September 30	2017			2016			Change
	(in thousands)
EBITDA		$	28,706		$	27,797		$	909
Acquisition-related cost of goods sold			249			—			249
Acquisition-related accrued compensation			437			420			17
Acquisition-related transaction costs			400			1,274			(874)
Foreign currency (gains) losses, net			325			334			(9)
Interest paid			(2,679)			(3,770)			1,091
Income taxes paid			(4,039)			(3,717)			(322)
Changes in operating assets and liabilities and other items			(18,196)			392			(18,588)
Cash used for acquisition-related transaction costs			(400)			(1,274)			874
Net cash provided (used) by operating activities		$	4,803		$	21,456		$	(16,653)

Certain amounts may reflect rounding adjustments.

Operating activities

Net cash provided by operating activities was $4.8 million for the three months ended September 30, 2017. Cash provided by net income and non-cash charges, including depreciation and amortization, was partially offset by $18.2 million of cash used in the ordinary course of business for changes in operating assets and liabilities and other items. Accounts receivable used $8.4 million of cash due to the timing of sales and collections in international regions. Increased inventories used $5.2 million of cash due to the timing of sales, purchases and production; a $3.7 million source of cash from increased accounts payable was primarily related to the timing of inventory purchases. Seasonality was a significant reason for the increases in inventories and accounts payable. Accrued expenses and other liabilities, excluding the effect of changes in accrued income tax and interest, used $4.4 million of cash primarily due to annual incentive compensation payments.

Investing activities

Net cash used in investing activities was $16.8 million for the three months ended September 30, 2017. Cash used for an acquisition of a business was $11.6 million. Capital expenditures were $5.0 million as we continued to invest in our existing asset base and for capacity expansion and productivity improvements. Other investing activities used $0.3 million of cash.

TABLE OF CONTENTS

Financing activities

Net cash provided by financing activities was $17.9 million for the three months ended September 30, 2017. Net borrowings on our Revolver provided $20.0 million. We received $3.5 million from the issuance of common shares related to the exercise of stock options. We paid $4.0 million in dividends to holders of our Class A and Class B common stock. We paid $1.7 million in scheduled debt and other requirements.

Liquidity and capital resources

We believe our cash on hand, our operating cash flows and our financing arrangements, including the availability of borrowings under the Revolver and foreign credit lines, will be sufficient to support our future cash needs. Our operating plan projects adequate liquidity throughout the year. However, we can provide no assurance that our liquidity and capital resources will be adequate for future funding requirements. We believe we will be able to comply with the terms of the covenants under the Credit Facilities and foreign credit lines based on our operating plan. In the event of adverse operating results and/or violation of covenants under the facilities, there can be no assurance we would be able to obtain waivers or amendments. Other risks to our meeting future funding requirements include global economic conditions and macroeconomic, business and financial disruptions that could arise. There can be no assurance that the challenging economic environment or an economic downturn would not impact our liquidity or our ability to obtain future financing. In addition, our debt covenants may restrict our ability to invest.

Certain relevant measures of our liquidity and capital resources follow:

As of	September 30, 2017			June 30, 2017			Change
	(in thousands, except ratios)
Cash and cash equivalents		$	62,097		$	56,083		$	6,014
Working capital			219,246			198,036			21,210
Ratio of current assets to current liabilities			2.94:1			2.81:1

We define working capital as total current assets (excluding cash and cash equivalents) less total current liabilities (excluding current portion of long-term debt). We calculate the ratio of current assets to current liabilities based on this definition.

At September 30, 2017, we had $85.0 million in outstanding borrowings under the Revolver. We had outstanding letters of credit and other commitments of $4.7 million, leaving $160.3 million available for borrowings and letters of credit.

We currently intend to pay quarterly dividends of $0.10 per share, representing $16.1 million annually on our Class A and Class B common stock, subject to approval from the Board of Directors. We declared and paid a cash dividend of $0.10 per share on Class A and Class B common stock during the three months ended September 30, 2017. On November 6, 2017, our Board of Directors declared a cash dividend of $0.10 per share on each share of our Class A and Class B common stock outstanding on the record date of December 6, 2017, payable on December 27, 2017.

At September 30, 2017, our cash and cash equivalents included $59.0 million held by our international subsidiaries. There are no restrictions on cash distributions to PAHC from our international subsidiaries.

Contractual obligations

As of September 30, 2017, there were no material changes in payments due under contractual obligations from those disclosed in the Annual Report on Form 10-K for the year ended June 30, 2017.

Off-balance sheet arrangements

We do not currently use off-balance sheet arrangements for the purpose of credit enhancement, hedging transactions, investment or other financial purposes.

TABLE OF CONTENTS

In the ordinary course of business, we may indemnify our counterparties against certain liabilities that may arise. These indemnifications typically pertain to environmental matters. If the indemnified party were to make a successful claim pursuant to the terms of the indemnification, we would be required to reimburse the loss. These indemnifications generally are subject to certain restrictions and limitations.

General description of non-GAAP financial measures

Adjusted EBITDA

Adjusted EBITDA is an alternative view of performance used by management as our primary operating measure, and we believe that investors’ understanding of our performance is enhanced by disclosing this performance measure. We report Adjusted EBITDA to portray the results of our operations prior to considering certain income statement elements. We have defined EBITDA as net income (loss) plus (i) interest expense, net, (ii) provision for income taxes or less benefit for income taxes, and (iii) depreciation and amortization. We have defined Adjusted EBITDA as EBITDA plus (a) (income) loss from, and disposal of, discontinued operations, (b) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (c) certain items that we consider to be unusual, non-operational or non-recurring. The Adjusted EBITDA measure is not, and should not be viewed as, a substitute for GAAP reported net income.

The Adjusted EBITDA measure is an important internal measurement for us. We measure our overall performance on this basis in conjunction with other performance metrics. The following are examples of how our Adjusted EBITDA measure is utilized:

•

senior management receives a monthly analysis of our operating results that is prepared on an Adjusted EBITDA basis;

•

our annual budgets are prepared on an Adjusted EBITDA basis; and

•

other goal setting and performance measurements are prepared on an Adjusted EBITDA basis.

Despite the importance of this measure to management in goal setting and performance measurement, Adjusted EBITDA is a non-GAAP financial measure that has no standardized meaning prescribed by GAAP and, therefore, has limits in its usefulness to investors. Because of its non-standardized definition, Adjusted EBITDA, unlike GAAP net income, may not be comparable to the calculation of similar measures of other companies. Adjusted EBITDA is presented to permit investors to more fully understand how management assesses performance.

We also recognize that, as an internal measure of performance, the Adjusted EBITDA measure has limitations, and we do not restrict our performance management process solely to this metric. A limitation of the Adjusted EBITDA measure is that it provides a view of our operations without including all events during a period, such as the depreciation of property, plant and equipment or amortization of purchased intangibles, and does not provide a comparable view of our performance to other companies.

Certain significant items

Adjusted EBITDA is calculated prior to considering certain items. We evaluate such items on an individual basis. Such evaluation considers both the quantitative and the qualitative aspect of their unusual or non-operational nature. Unusual, in this context, may represent items that are not part of our ongoing business; items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis. An example of an unusual item is the loss on extinguishment of debt incurred in fiscal year 2017. We consider foreign currency gains and losses to be non-operational because they arise principally from intercompany transactions and are largely non-cash in nature.

New accounting standards

For discussion of new accounting standards, see “Notes to Consolidated Financial Statements—Summary of Significant Accounting Policies and New Accounting Standards.”

TABLE OF CONTENTS

Critical Accounting Policies

Critical accounting policies are those that require application of management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods. Not all of these significant accounting policies require management to make difficult, subjective or complex judgments or estimates. However, management is required to make certain estimates and assumptions during the preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. Significant estimates include depreciation and amortization periods of long-lived and intangible assets, recoverability of long-lived and intangible assets and goodwill, realizability of deferred income tax and value-added tax assets, legal and environmental matters and actuarial assumptions related to our pension plans. These estimates and assumptions impact the reported amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements. Estimates and assumptions are reviewed periodically and the effects of revisions are reflected in the period they are determined to be necessary. Actual results could differ from those estimates. Our significant accounting policies are described in the notes to the consolidated financial statements included in the Annual Report. As of September 30, 2017, there have been no material changes to any of the critical accounting policies contained therein.

Forward-Looking Statements

This report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements discuss our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as “aim,” “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “outlook,” “potential,” “project,” “projection,” “plan,” “intend,” “seek,” “believe,” “may,” “could,” “would,” “will,” “should,” “can,” “can have,” “likely,” the negatives thereof and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected earnings, revenues, costs, expenditures, cash flows, growth rates and financial results, our plans and objectives for future operations, growth or initiatives, strategies, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected. Examples of such risks and uncertainties include:

•

perceived adverse effects on human health linked to the consumption of food derived from animals that utilize our products could cause a decline in the sales of those products;

•

restrictions on the use of antibacterials in food-producing animals may become more prevalent;

•

a material portion of our sales and gross profits are generated by antibacterials and other related products;

•

competition in each of our markets from a number of large and small companies, some of which have greater financial, research and development (“R&D”), production and other resources than we have;

•

the impact of current and future laws and regulatory changes;

•

outbreaks of animal diseases could significantly reduce demand for our products;

•

our ability to successfully implement several of our strategic initiatives;

•

our business may be negatively affected by weather conditions and the availability of natural resources;

•

the continuing trend toward consolidation of certain customer groups as well as the emergence of large buying groups;

TABLE OF CONTENTS

•

our ability to control costs and expenses;

•

any unforeseen material loss or casualty;

•

exposure relating to rising costs and reduced customer income;

•

competition deriving from advances in veterinary medical practices and animal health technologies;

•

unanticipated safety or efficacy concerns;

•

our dependence on suppliers having current regulatory approvals;

•

our raw materials are subject to price fluctuations and their availability can be limited;

•

natural and man-made disasters, including but not limited to fire, snow and ice storms, flood, hail, hurricanes and earthquakes;

•

terrorist attacks, particularly attacks on or within markets in which we operate;

•

our reliance on the continued operation of our manufacturing facilities and application of our intellectual property;

•

adverse U.S. and international economic market conditions, including currency fluctuations;

•

the risks of product liability claims, legal proceedings and general litigation expenses;

•

our dependence on our Israeli and Brazilian operations;

•

our substantial level of indebtedness and related debt-service obligations;

•

restrictions imposed by covenants in our debt agreements;

•

the risk of work stoppages; and

•

other factors as described in “Risk Factors” in Item 1A. of the Annual Report.

While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations, or cautionary statements, are disclosed under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Annual Report. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. The forward-looking statements included in this report are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

In the normal course of operations, we are exposed to market risks arising from adverse changes in interest rates, foreign currency exchange rates and commodity prices. As a result, future earnings, cash flows and fair values of assets and liabilities are subject to uncertainty. We use, from time to time, foreign currency contracts and interest rate swaps as a means of hedging exposure to foreign currency risks and fluctuating interest rates, respectively. We also utilize, on a limited basis, certain commodity derivatives, primarily on copper used in manufacturing processes, to hedge the cost of anticipated purchase or supply

TABLE OF CONTENTS

requirements. We do not utilize derivative instruments for trading or speculative purposes. We do not hedge our exposure to market risks in a manner that completely eliminates the effects of changing market conditions on earnings, cash flows and fair values. We monitor the financial stability and credit standing of our major counterparties.

For financial market risks related to changes in interest rates, foreign currency exchange rates and commodity prices, reference is made to the “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Qualitative and Quantitative Disclosures about Market Risk” section in the Annual Report and to the notes to the consolidated financial statements included therein. There were no material changes in the Company’s financial market risks from the risks disclosed in the Annual Report.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation was carried out under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)). Based upon that evaluation as of September 30, 2017, our Chief Executive Officer and Chief Financial Officer each concluded that, as of the end of such period, our disclosure controls and procedures were not effective because of material weaknesses in our internal control over financial reporting, as described in Management’s Report on Internal Control over Financial Reporting in “Item 9A. Controls and Procedures” in the Annual Report on Form 10-K for the year ended June 30, 2017.

Management’s Remediation Plan

We are in the process of implementing a broad range of changes to our internal control over financial reporting to remediate the material weaknesses that existed as of June 30, 2017. Our actions to address material weaknesses have included the design and implementation of additional formal accounting policies and procedures to ensure transactions are properly initiated, recorded, processed, reported, appropriately authorized and approved. Also, our efforts to ensure maintenance of the appropriate level of segregation of duties includes restricting access to key financial systems and records to appropriate users. We are determining the extent it is necessary to limit access by and modify responsibilities of certain personnel, as well as designing and implementing additional user access controls and compensating controls. We will continue to build on the progress we have made in our remediation plan. We cannot determine when our remediation plan will be fully completed, and we cannot provide any assurance that these remediation efforts will be successful or that our internal control over financial reporting will be effective as a result of these efforts.

Changes in Internal Control over Financial Reporting

There have been no changes in internal control over financial reporting during the three months ended September 30, 2017, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

TABLE OF CONTENTS

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

Information required by this Item is incorporated herein by reference to “Notes to the Consolidated Financial Statements—Commitments and Contingencies” in Part I, Item 1, of this Quarterly Report on Form 10-Q.

Item 1A.

Risk Factors

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in the “Risk Factors” section in the Annual Report, which could materially affect our business, financial condition or future results.

There were no material changes in the Company’s risk factors from the risks disclosed in the Annual Report.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None.

Item 6.

Exhibits

				Exhibit 31.1 Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
				Exhibit 31.2 Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 302
				Exhibit 32.1 Chief Executive Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
				Exhibit 32.2 Chief Financial Officer—Certification pursuant to Sarbanes-Oxley Act of 2002 Section 906
				Exhibit 101.INS* XBRL Instance Document
				Exhibit 101.SCH* XBRL Taxonomy Extension Schema Document
				Exhibit 101.CAL* XBRL Taxonomy Extension Calculation Linkbase Document
				Exhibit 101.DEF* XBRL Taxonomy Extension Definition Linkbase Document
				Exhibit 101.LAB* XBRL Taxonomy Extension Label Linkbase Document
				Exhibit 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document

Furnished with this Quarterly Report. Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933 and are deemed not filed for purposes of section 18 of the Exchange Act.

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Phibro Animal Health Corporation
November 6, 2017	By:	/s/ Jack C. Bendheim Jack C. Bendheim Chairman, President and Chief Executive Officer
November 6, 2017	By:	/s/ Richard G. Johnson Richard G. Johnson Chief Financial Officer

EX-31.1 2 t1702887_ex31-1.htm EXHIBIT 31.1 t1702887-10q_DIV_06-ex31-1 - none - 0.7304968s

EXHIBIT 31.1

CERTIFICATIONS

I, Jack C. Bendheim, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 6, 2017

/s/ Jack C. Bendheim

Jack C. Bendheim
Chairman, President and Chief Executive Officer

EX-31.2 3 t1702887_ex31-2.htm EXHIBIT 31.2 t1702887-10q_DIV_07-ex31-2 - none - 0.7119414s

EXHIBIT 31.2

CERTIFICATIONS

I, Richard G. Johnson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Phibro Animal Health Corporation;

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 6, 2017

/s/ Richard G. Johnson

Richard G. Johnson
Chief Financial Officer

EX-32.1 4 t1702887_ex32-1.htm EXHIBIT 32.1 t1702887-10q_DIV_08-ex32-1 - none - 0.7256138s

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this periodic report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in this periodic report fairly presents, in all material respects, the financial condition and results of operations of the issuer.

Dated: November 6, 2017

/s/ Jack C. Bendheim

Jack C. Bendheim
Chairman, President and Chief Executive Officer

EX-32.2 5 t1702887_ex32-2.htm EXHIBIT 32.2 t1702887-10q_DIV_09-ex32-2 - none - 0.7490522s

EXHIBIT 32.2

CERTIFICATION UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Dated: November 6, 2017

/s/ Richard G. Johnson

Richard G. Johnson
Chief Financial Officer

EX-101.INS 6 pahc-20170930.xml XBRL INSTANCE FILE 0001069899 2012-09-01 2012-09-30 0001069899 2016-07-01 2016-09-30 0001069899 us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember pahc:CompensationAndBenefitForServicesMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2016-07-01 2016-09-30 0001069899 pahc:TermALoansMember 2016-07-01 2016-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2016-07-01 2016-09-30 0001069899 pahc:MfasAndOtherMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 us-gaap:OperatingSegmentsMember 2016-07-01 2016-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2016-07-01 2017-06-30 0001069899 us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember us-gaap:StockOptionMember 2016-07-01 2017-06-30 0001069899 2017-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2017-06-30 0001069899 us-gaap:CorporateNonSegmentMember 2017-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2017-06-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2017-06-30 0001069899 pahc:TermALoansMember 2017-06-30 0001069899 us-gaap:OperatingSegmentsMember 2017-06-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0001069899 us-gaap:CommonClassAMember 2017-06-30 0001069899 us-gaap:CommonClassBMember 2017-06-30 0001069899 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-06-30 0001069899 pahc:AnimalHealthMember 2017-06-30 0001069899 pahc:PerformanceProductsMember 2017-06-30 0001069899 us-gaap:OtherCurrentAssetsMember us-gaap:StockOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2017-06-30 0001069899 us-gaap:InterestRateSwapMember 2017-07-31 0001069899 2017-07-01 2017-09-30 0001069899 us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember pahc:CompensationAndBenefitForServicesMember 2017-07-01 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2017-07-01 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2017-07-01 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2017-07-01 2017-09-30 0001069899 pahc:TermALoansMember 2017-07-01 2017-09-30 0001069899 us-gaap:RevolvingCreditFacilityMember 2017-07-01 2017-09-30 0001069899 pahc:MfasAndOtherMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2017-07-01 2017-09-30 0001069899 pahc:NutritionalSpecialtiesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2017-07-01 2017-09-30 0001069899 pahc:VaccinesMember pahc:AnimalHealthMember us-gaap:OperatingSegmentsMember 2017-07-01 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember 2017-07-01 2017-09-30 0001069899 pahc:CurrentAndLongTermLiabilitiesMember 2017-07-01 2017-09-30 0001069899 us-gaap:LongMember us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember us-gaap:StockOptionMember 2017-07-01 2017-09-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-07-01 2017-09-30 0001069899 us-gaap:OtherComprehensiveIncomeMember us-gaap:LongMember us-gaap:StockOptionMember us-gaap:CashFlowHedgingMember 2017-07-01 2017-09-30 0001069899 pahc:CreditAgreementMember pahc:TermALoansAndRevolvingCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-07-01 2017-09-30 0001069899 pahc:CreditAgreementMember pahc:TermALoansAndRevolvingCreditFacilityMember us-gaap:BaseRateMember 2017-07-01 2017-09-30 0001069899 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:PerformanceProductsMember 2017-09-30 0001069899 us-gaap:CorporateNonSegmentMember 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:AnimalHealthMember 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember pahc:MineralNutritionMember 2017-09-30 0001069899 pahc:TermALoansMember 2017-09-30 0001069899 us-gaap:OperatingSegmentsMember 2017-09-30 0001069899 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-09-30 0001069899 us-gaap:CommonClassAMember 2017-09-30 0001069899 us-gaap:CommonClassBMember 2017-09-30 0001069899 us-gaap:CapitalLeaseObligationsMember 2017-09-30 0001069899 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-09-30 0001069899 pahc:AnimalHealthMember 2017-09-30 0001069899 pahc:PerformanceProductsMember 2017-09-30 0001069899 pahc:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember 2017-09-30 0001069899 us-gaap:StockOptionMember us-gaap:CashFlowHedgingMember us-gaap:LongMember 2017-09-30 0001069899 us-gaap:SwapMember us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember 2017-09-30 0001069899 pahc:CreditAgreementMember pahc:TermALoanMember 2017-09-30 0001069899 us-gaap:CommonClassAMember 2017-10-30 0001069899 us-gaap:CommonClassBMember 2017-10-30 0001069899 2016-06-30 0001069899 2016-09-30 xbrli:shares iso4217:USD iso4217:USDxbrli:shares xbrli:pure pahc:PRPs iso4217:BRL PHIBRO ANIMAL HEALTH CORP 0001069899 pahc --06-30 Accelerated Filer 19581889 20602836 10-Q 2017-09-30 false 2018 Q1

187987000

11894000

124501000

51592000

83419000

26304000

14778000

187987000

193412000

12498000

128841000

52073000

79603000

30777000

18461000

193412000

126988000

130030000

60999000

63382000

39186000

40995000

21813000

22387000

-3907000

-3118000

-334000

-325000

17572000

18944000

5395000

3052000

12177000

15892000

0.31

0.40

0.31

0.39

39408000

39944000

39906000

40293000

0.10

34000

-622000

-893000

3233000

-7169000

-131000

2750000

-187000

3560000

2929000

15737000

18821000

56083000

62097000

33605000

37415000

125847000

136337000

161233000

170928000

20502000

25193000

363665000

394555000

127351000

131242000

54602000

64457000

23982000

53797000

56875000

623397000

23681000

102011000

442521000

55184000

521386000

671111000

22331000

109334000

479075000

60371000

561777000

6250000

7895000

56894000

61732000

52652000

51480000

115796000

121107000

65000000

85000000

49553000

56570000

472240000

501636000

4000

123840000

127326000

82750000

94653000

-55437000

-52508000

151157000

169475000

623397000

671111000

0.0001

300000000

30000000

300000000

30000000

19249132

20626836

19555839

20614836

19249132

20626836

19555839

20614836

0.0001

16000000

6318000

218000

4898000

542000

5658000

6644000

246000

5254000

585000

6085000

253000

221000

249000

420000

437000

393000

253000

1706000

770000

-97000

-345000

-87000

-213000

-3906000

8386000

-4544000

5196000

2430000

4458000

-346000

-332000

-5004000

3652000

-1357000

-6165000

21456000

4803000

5911000

4998000

11562000

-25000

272000

-5886000

-16832000

34000000

61870000

41000000

41870000

729000

1652000

3486000

3941000

3989000

-11670000

17845000

-90000

198000

3810000

6014000

<div style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; break-after: page;"> <div style="text-align: left; line-height: 11pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt; float: left; white-space: nowrap;">3.     Statements of Operations—Additional Information</div> <div style="margin: 0pt; padding: 0pt; line-height: 0pt; clear: both; font-size: 0pt;"> </div> <table style="width: 55%; height: 220px; margin-top: 7pt; border-collapse: collapse;" border="0"> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.5pt; width: 348pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; text-align: center; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 2pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">For the Periods Ended September 30</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="padding-right: 12pt; padding-bottom: 1pt; padding-left: 12pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="padding-right: 14pt; padding-bottom: 1pt; padding-left: 14pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2016</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 348pt;">Interest expense, net</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Term loan</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">2,033</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">2,905</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Revolving credit facility</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">681</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">955</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Amortization of debt issuance costs and debt discount</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">221</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">253</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">253</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">393</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 348pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Other</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">239</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">81</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Interest expense</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">3,427</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">4,587</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 348pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Interest (income)</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">(309<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">(680<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 348pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 17.25pt;">3,118</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 17.25pt;">3,907</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.25pt 0pt 1pt; width: 348pt;">Depreciation and amortization</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Depreciation of property, plant and equipment</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">5,183</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">4,731</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 348pt; text-align: left;"> <div style="white-space: nowrap;">Amortization of intangible assets</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">1,449</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">1,528</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 348pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Amortization of other assets</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">12</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 17.25pt;">59</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 348pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 17.25pt;">6,644</td> <td style="padding: 0pt 0pt 0pt 5.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 17.25pt;">6,318</td> <td style="padding: 0pt 0pt 0pt 8.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> </div>

<div style="text-align: left; color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: bold; margin-top: 10pt; margin-bottom: 0pt; word-spacing: 0px; float: left; white-space: nowrap; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">4.     Balance Sheets—Additional Information</div> <div style="margin: 0pt; padding: 0pt; color: #000000; text-transform: none; line-height: 0pt; text-indent: 0px; letter-spacing: normal; clear: both; font-family: 'times new roman', times, serif; font-size: 0pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 376pt; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 88pt; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt;">Inventories</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Raw materials</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">57,719</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">54,861</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Work-in-process</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">12,014</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">12,402</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 250pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Finished goods</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">101,195</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">93,970</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">170,928</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">161,233</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 13.49pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In September 2017, we acquired a business for approximately $15,000, including approximately $3,500 paid subsequent to September 30, 2017. The business develops, manufactures and markets animal health products. We accounted for the acquisition as a business combination in accordance with ASC 805, <font style="font-style: italic;">Business Combinations</font>. Pro forma information giving effect to the acquisition has not been provided because the results are not material to the consolidated financial statements. Net assets acquired included accounts receivable, inventories, property, plant and equipment, intangible assets, accounts payable and accrued expenses. We expect to refine the valuation of certain assets and liabilities during the measurement period. The business is included in the Animal Health segment.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Goodwill balances did not change during the three months ended September 30, 2017.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $3,802 equity investment are currently idled; we have concluded the investment is not currently impaired, based on expected future operating cash flows and/or disposal value.</div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 1pt; text-indent: 0px; width: 376pt; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 130pt; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt;">Accrued expenses and other current liabilities</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Employee related</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">21,030</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">26,553</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Commissions and rebates</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">4,964</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">6,443</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Insurance related</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">1,522</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">1,515</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Professional fees</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,513</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,823</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Income and other taxes</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,631</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,035</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 250pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Other</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 21pt;">16,820</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 21pt;">11,283</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 21pt;">51,480</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 21pt;">52,652</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 13pt; text-indent: 0px; width: 376pt; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 166pt; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt; text-align: left;">Accumulated other comprehensive income (loss)</td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Derivative instruments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">2,064</td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">2,686</td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Foreign currency translation adjustment</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(40,323<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(43,556<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Unrecognized net pension gains (losses)</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(17,928<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(18,059<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 250pt; text-align: left; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on derivative instruments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(1,316<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(1,553<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 250pt; text-align: left; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for incomes taxes on long-term intercompany investments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">8,166</td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">8,166</td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 1.333pt; width: 250pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on pension gains (losses)</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 23.25pt;">(3,171<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 23.25pt;">(3,121<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 23.25pt;">(52,508<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 23.25pt;">(55,437<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table>

<div style="text-align: left; color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; margin-top: 13pt; margin-bottom: 0pt; word-spacing: 0px; float: left; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">9.     Derivatives</div> <div style="margin: 0pt; padding: 0pt; color: #000000; text-transform: none; line-height: 0pt; text-indent: 0px; letter-spacing: normal; clear: both; font-family: 'times new roman', times, serif; font-size: 0pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We monitor our exposure to foreign currency exchange rates and interest rates and from time-to-time use derivatives to manage certain of these risks. We designate derivatives as a hedge of a forecasted transaction or of the variability of the cash flows to be received or paid in the future related to a recognized asset or liability (cash flow hedge). All changes in the fair value of a highly effective cash flow hedge are recorded in accumulated other comprehensive income (loss).</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We routinely assess whether the derivatives used to hedge transactions are effective. If we determine a derivative ceases to be an effective hedge, we discontinue hedge accounting in the period of the assessment for that derivative, and immediately recognize any unrealized gains or losses related to the fair value of that derivative in the consolidated statements of operations.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “—Fair Value Measurements.”</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The following tables detail the Company’s outstanding derivatives that are designated and effective as cash flow hedges as of September 30, 2017:</div> <table style="width: 456pt; height: 63.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10.66px; font-style: normal; font-weight: normal; margin-top: 8pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="height: 14.25pt; text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 2pt; width: 105.51pt; text-align: left;" rowspan="2"> <div style="line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">Instrument</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 2pt; width: 80.51pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;">Hedge</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 2pt; width: 47.41pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt;">Notional <br />Amount at <br />September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="13"> <div style="text-align: center; white-space: nowrap;">Fair value as of</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="height: 0pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; width: 84.74pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="text-align: center;">Consolidated <br />Balance Sheet</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">June 30, <br />2017</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 105.51pt; text-align: left;"> <div style="white-space: nowrap;">Options</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0.5pt 1pt 0pt; width: 80.51pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real calls </div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; width: 47.41pt; text-align: center;"> <div style="text-align: center;">R$19,500</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; width: 84.74pt; text-align: left;"> <div style="white-space: nowrap;">Other current assets</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">1,781</td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 18.75pt;"> 2,686</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 105.51pt; text-align: left;"> <div style="white-space: nowrap;">Swap</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0.5pt 1pt 0pt; width: 80.51pt;"> <div style="text-align: right;">Interest rate swap </div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0pt 1pt; width: 47.41pt; text-align: center;"> <div style="text-align: center;">$ 150,000</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0pt 1pt; width: 84.74pt; text-align: left;">Other assets</td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">283</td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 18.75pt;"> —</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table> <table style="width: 456pt; height: 101pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10.66px; font-style: normal; font-weight: normal; margin-top: 11pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="height: 26.75pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 39pt; text-align: left;" rowspan="2"> <div style="line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">Instrument</font></div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 44pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;">Hedge</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Gain (loss) recorded in OCI</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="13"> <div style="text-align: center;">Gain (loss) recognized in <br />consolidated statements of operations</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center;">Consolidated Statement <br />of Operations Line <br />Item Total</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="height: 0pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; width: 46.13pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="text-align: center;">Consolidated <br />Statement<br />of Operations</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.417pt 0pt 0.5pt; width: 39pt; text-align: left;"> <div style="white-space: nowrap;">Options</div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; width: 44pt; text-align: left;">Brazilian <br />Real calls</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">(905<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 7.5pt;">34</td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; width: 46.13pt; text-align: left;">Cost of <br />goods sold</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 9pt;">186</td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 15.75pt;">(1,135<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">130,030</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">126,988</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 39pt; text-align: left;"> <div style="white-space: nowrap;">Swap</div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.667pt 0.5pt 0.5pt 0pt; width: 44pt;"> <div style="text-align: right;">Interest rate<br />swap </div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">283</td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 7.5pt;"> —</td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; width: 46.13pt; text-align: left;">Interest <br />expense, net</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 9pt;"> —</td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 15.75pt;"> —</td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">3,118</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">3,907</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 14.4pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The foreign currency derivatives generally have an expiration or maturity of two years or less and are intended to hedge cash flows related to the purchase of inventory. These forecasted transactions are probable of occurring. As the hedged item is sold, we recognize the gain or loss recorded in accumulated other comprehensive income (loss) to the consolidated statements of operations on the same line where the hedged item is charged when released/sold. The fair values of the foreign currency options as of September 30, 2017, are unrealized and will fluctuate based on future exchange rates until the derivative contracts mature. Accumulated other comprehensive income (loss) at September 30, 2017 included $1,781 of net unrecognized gains on derivative instruments; we estimate the entire amount will be recognized in earnings within the next twelve months. At September 30, 2017, realized gains of $1,622 related to matured contracts were recorded as a component of inventory. We anticipate these gains will be recognized as an offset to cost of goods sold within the next twelve months. At June 30, 2017, net realized gains of  $966 related to matured contracts were recorded as a component of inventory. We recognized $186 of these gains in cost of goods sold during the three months September 30, 2017, and anticipate we will recognize the remaining $780 of these gains in costs of goods sold in the next six months. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; margin-top: 14.4pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">In July 2017, we entered into an interest rate swap agreement on $150,000 of notional principal that effectively converts the floating LIBOR or base rate portion of our interest obligation on that amount of debt, to a fixed interest rate of 1.8325% plus the applicable rate. The agreement matures concurrent with the Credit Agreement. The forecasted transactions are probable of occurring, and the interest rate swap has been designated as a highly effective cash flow hedge. The fair value of the interest rate swap agreement is recorded as an asset or liability with a corresponding amount included in accumulated other comprehensive income (loss).</div>

<div> <div style="text-align: left; color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt; word-spacing: 0px; float: left; white-space: nowrap; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">10.    Fair Value Measurements</div> <div style="margin: 0pt; padding: 0pt; color: #000000; text-transform: none; line-height: 0pt; text-indent: 0px; letter-spacing: normal; clear: both; font-family: 'times new roman', times, serif; font-size: 0pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </div> <div style="color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: italic; font-weight: normal; margin-top: 12pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Contingent Consideration on Acquisitions</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We determine the fair value of contingent consideration on acquisitions based on contractual terms, our current forecast of performance factors related to the acquired business and an applicable discount rate.</div> <div style="color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: italic; font-weight: normal; margin-top: 12pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Derivatives</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We determine the fair value of derivative instruments based upon pricing models using observable market inputs for these types of financial instruments, such as spot and forward currency translation rates, and interest rate curves.</div> <div style="color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: italic; font-weight: normal; margin-top: 12pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Fair Value of Assets (Liabilities)</div> <table style="width: 45%; height: 75px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 7pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 2pt; width: 139.06pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="16"> <div style="text-align: center; white-space: nowrap;">September 30, 2017</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="16"> <div style="text-align: center; white-space: nowrap;">June 30, 2017</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.5pt; width: 139.06pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 139.06pt; text-align: left;"> <div style="white-space: nowrap;">Derivatives asset</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;"> —</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">1,781</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;"> —</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;"> —</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">2,686</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 139.06pt; text-align: left;"> <div style="white-space: nowrap;">Interest rate swap</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">—</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">283</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">—</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 1pt; width: 139.06pt; text-align: left;"> <div style="text-indent: -10pt; margin-left: 10pt;">Contingent consideration on <br />acquisitions</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">—</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">(7,827<font style="position: absolute;">)</font></td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">—</td> <td style="padding: 0pt 0pt 0pt 1.865pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 1.667pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">(7,644<font style="position: absolute;">)</font></td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 16.98pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The table below provides a summary of the changes in the fair value of Level 3 assets (liabilities):</div> <table style="width: 45%; height: 52px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 8pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; width: 332.96pt; text-align: left;"> <div style="white-space: nowrap;">Balance, June 30, 2017</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">(7,644<font style="position: absolute;">)</font></td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; width: 332.96pt; text-align: left;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">(253<font style="position: absolute;">)</font></td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; width: 332.96pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Payment</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 19.5pt;">70</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt; width: 332.96pt; text-align: left;"> <div style="white-space: nowrap;">Balance, September 30, 2017</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 19.5pt;">(7,827<font style="position: absolute;">)</font></td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="9"> </td> </tr> </table> </div>

<div> <div style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; break-after: page;"> <div style="text-align: left; line-height: 11pt; font-weight: bold; margin-top: 0pt; margin-bottom: 0pt; float: left; white-space: nowrap;">11.    Business Segments</div> <div style="margin: 0pt; padding: 0pt; line-height: 0pt; clear: both; font-size: 0pt;"> </div> <div style="line-height: 12pt; text-indent: 40pt; margin-top: 6pt;">The Animal Health segment manufactures and markets a broad range of products for food animals, including poultry, swine, cattle, dairy and aquaculture. The business includes net sales of medicated feed additives and other related products, nutritional specialty products and vaccines. The Mineral Nutrition segment manufactures and markets a broad range of trace minerals for food animals. The Performance Products segment manufactures and markets a variety of products for use in the personal care, automotive, industrial chemical and chemical catalyst industries.</div> <div style="line-height: 12pt; text-indent: 40pt; margin-top: 6pt;">We evaluate performance and allocate resources based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to these segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, business technology, legal, finance, human resources and business development. Corporate assets include cash and cash equivalents, certain debt issue costs, income tax related assets and certain other assets.</div> </div> <div style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; break-after: page;"> <div style="line-height: 12pt; text-indent: 40pt; margin-top: 10pt;">We evaluate performance of our segments based on Adjusted EBITDA. We define Adjusted EBITDA as income before income taxes plus (a) interest expense, net, (b) depreciation and amortization, (c) (income) loss from, and disposal of, discontinued operations, (d) other expense or less other income, as separately reported on our consolidated statements of operations, including foreign currency gains and losses and loss on extinguishment of debt, and (e) certain items that we consider to be unusual, non-operational or non-recurring.</div> <div style="line-height: 12pt; text-indent: 40pt; margin-top: 6pt;">The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.</div> <table style="width: 55%; height: 453px; margin-top: 8pt; border-collapse: collapse;" border="0"> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.5pt; width: 356.59pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; text-align: center; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 2pt; width: 356.59pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">For the Periods Ended September 30</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="padding-right: 11pt; padding-bottom: 1pt; padding-left: 11pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.75pt 0pt 2pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="padding-right: 11pt; padding-bottom: 1pt; padding-left: 11pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2016</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 356.59pt;">Net sales</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">MFAs and other</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">79,603</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">83,419</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Nutritional Specialties</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">30,777</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">26,304</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 356.59pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 20pt;">Vaccines</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">18,461</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">14,778</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">128,841</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">124,501</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">52,073</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">51,592</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 356.59pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">12,498</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">11,894</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">193,412</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">187,987</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 8.25pt 0pt 1pt; width: 356.59pt;">Depreciation and amortization</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">5,254</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">4,898</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">585</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">542</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 356.59pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">246</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">218</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">6,085</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">5,658</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 8.25pt 0pt 1pt; width: 356.59pt;">Adjusted EBITDA</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">33,742</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">32,619</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">3,716</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">3,988</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 356.59pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">248</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">742</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">37,706</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">37,349</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 8.25pt 0pt 1pt; width: 356.59pt;">Reconciliation of income before income taxes to Adjusted EBITDA</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Income before income taxes</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">18,944</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">17,572</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Interest expense, net</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">3,118</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">3,907</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Depreciation and amortization – Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">6,085</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">5,658</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Depreciation and amortization – Corporate</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">559</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">660</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Corporate costs</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">7,589</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">7,524</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Acquisition-related cost of goods sold</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">249</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">—</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Acquisition-related accrued compensation</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">437</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">420</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 20pt;">Acquisition-related transaction costs</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">400</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">1,274</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 356.59pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 20pt;">Foreign currency (gains) losses, net</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">325</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">334</td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt; width: 356.59pt; text-align: left;"> <div style="margin-left: 10pt;">Adjusted EBITDA – Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">37,706</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">37,349</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> </div> <div style="color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; break-after: page;"> <table style="width: 45%; height: 116px; margin-top: 10pt; margin-left: 40pt; border-collapse: collapse;" border="0"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 252pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 18pt; padding-bottom: 1pt; padding-left: 18pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 252pt;">Identifiable assets</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 252pt; text-align: left;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">479,075</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">442,521</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 252pt; text-align: left;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">60,371</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">55,184</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 252pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">22,331</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">23,681</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 252pt; text-align: left;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">561,777</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">521,386</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 252pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="margin-left: 10pt;">Corporate</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">109,334</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">102,011</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt; width: 252pt; text-align: left;"> <div style="margin-left: 10pt;">Total</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">671,111</td> <td style="padding: 0pt 0pt 0pt 4.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">623,397</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> <div style="line-height: 12pt; text-indent: 40pt; margin-top: 13.48pt;">The Animal Health segment includes all goodwill of the Company. The Animal Health segment includes advances to and investment in an equity method investee of  $3,802 and $3,719 as of September 30, 2017 and June 30, 2017, respectively. The Performance Products segment includes an investment in equity method investee of  $559 and $516 as of September 30, 2017 and June 30, 2017, respectively. Corporate assets include cash and cash equivalents, certain debt issuance costs, income tax related assets and certain other assets.</div> </div> </div>

<div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: 1; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Net Income per Share and Weighted Average Shares</font></div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.</font></div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><font style="font-family: times new roman,times;" size="2">Diluted net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period after giving effect to potential dilutive common shares resulting from the assumed exercise of stock options. For the three months ended September 30, 2017 and 2016, all common share equivalents were included in the calculation of diluted net income per share.</font></div> <table style="widows: 2; text-transform: none; font-style: normal; margin-top: 10pt; text-indent: 0px; width: 38%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 121px; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;"><font style="font-family: times new roman,times;" size="2">Three Months</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt; ; font-family: times new roman,times;" size="2">For the Periods Ended September 30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt; ; font-family: times new roman,times;" size="2">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt; ; font-family: times new roman,times;" size="2">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="font-family: times new roman,times;" size="2">Net income</font></div> </td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">15,892</font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">12,177</font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.25pt;"> <div style="white-space: nowrap;"><font style="font-family: times new roman,times;" size="2">Weighted average number of shares – basic</font></div> </td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;"><font style="font-family: times new roman,times;" size="2">39,944</font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;"><font style="font-family: times new roman,times;" size="2">39,408</font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;"><font style="font-family: times new roman,times;" size="2">Dilutive effect of stock options</font></div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">349</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">499</font></td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="font-family: times new roman,times;" size="2">Weighted average number of shares – diluted</font></div> </td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">40,293</font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"><font style="font-family: times new roman,times;" size="2">39,906</font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">Net income per share</font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td colspan="6"><font style="font-family: times new roman,times;" size="2"> </font></td> <td colspan="6"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;"><font style="font-family: times new roman,times;" size="2">basic</font></div> </td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">0.40</font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">0.31</font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;"><font style="font-family: times new roman,times;" size="2">diluted</font></div> </td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">0.39</font></td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 6pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">$</font></td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;"><font style="font-family: times new roman,times;" size="2">0.31</font></td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> <td style="width: 0pt; padding: 0pt;"><font style="font-family: times new roman,times;" size="2"> </font></td> </tr> </table>

<div style="line-height: 11pt; widows: 2; text-transform: none; font-style: italic; margin-top: pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Dividends</div> <div style="line-height: 12pt; widows: 2; text-transform: none; font-style: normal; margin-top: 6pt; text-indent: 40pt; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">We declared and paid quarterly cash dividends of $0.10 per share, totaling $3,989 during the three months ended September 30, 2017, to holders of our Class A common stock and Class B common stock.</div>

<div style="color: #000000; text-transform: none; line-height: 11pt; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: italic; font-weight: normal; margin-top: 12pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">New Accounting Standards</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2017-12, <font style="font-style: italic;">Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities</font> simplifies the application of hedge accounting guidance and improves the financial reporting of hedging relationships to better portray the economic results of an entity’s risk management activities in its financial statements. During the three months ended September 30, 2017, we elected early adoption of this guidance and applied the qualitative method, and it did not have a material effect on our consolidated financial statements. For additional details, see “—Derivatives.”</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">ASU 2016-15, <font style="font-style: italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font>, provides specific guidance for the classification of certain transactions within the statement of cash flows. The issues addressed by this guidance include, but are not limited to, debt prepayments or debt extinguishment costs, contingent consideration payments made after a business combination and proceeds from the settlement of insurance claims. This ASU is effective for annual reporting periods beginning after December 15, 2017. Early application is permitted, as long as all provisions under the guidance are applied simultaneously. The provisions of this guidance are to be applied using a retrospective transition approach. We do not expect adoption of this guidance to have a material effect on our consolidated financial statements.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">ASU 2016-02, <font style="font-style: italic;">Leases (Topic 842)</font>, supersedes the current lease accounting guidance, requires an entity to recognize assets and liabilities for both financing and operating leases on the balance sheet and requires additional qualitative and quantitative disclosures regarding leasing arrangements. This ASU is effective for annual reporting periods beginning after December 15, 2018. We are evaluating the effect of adoption of this guidance on our consolidated financial statements.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">ASU 2015-11, <font style="font-style: italic;">Inventory (Topic 330)</font>, requires entities to measure inventory at the lower of cost and net realizable value (“NRV”). NRV is defined as “the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.” We applied this guidance during the three months ended September 30, 2017, and it did not have a material effect on our consolidated financial statements.</div> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 6pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">ASU 2014-09, <font style="font-style: italic;">Revenue from Contracts with Customers (Topic 606)</font>, establishes principles for the recognition of revenue from contracts with customers. The underlying principle is to identify the performance obligations of a contract, allocate the revenue to each performance obligation and then to recognize revenue when the company satisfies a specific performance obligation of the contract. ASU 2014-09 and its amendments are effective for our consolidated financial statements beginning July 1, 2018. We expect to apply the new standard using the modified retrospective method. We continue to evaluate the effect that the adoption of this guidance may have on our consolidated financial statements.</div>

<table style="width: 38%; height: 121px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13px; font-style: normal; font-weight: normal; margin-top: 0pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September 30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Net income</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">15,892</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">12,177</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.25pt;"> <div style="white-space: nowrap;">Weighted average number of shares – basic</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;"> </td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,944</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.25pt;"> </td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.25pt;">39,408</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Dilutive effect of stock options</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">349</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 21pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">498</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Weighted average number of shares – diluted</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">40,293</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">39,906</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;">Net income per share</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">basic</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.40</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">diluted</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.39</td> <td style="padding-bottom: 0pt; padding-left: 3.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 21pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">0.31</td> <td style="padding-bottom: 0pt; padding-left: 6.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> </table>

<table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 456pt; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 220.5pt; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September 30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 12pt; padding-right: 12pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 14pt; padding-right: 14pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;">Interest expense, net</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Term loan</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,033</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">2,905</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Revolving credit facility</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">681</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">955</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of debt issuance costs and debt discount</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">221</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">253</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">253</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">393</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Other</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">239</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">81</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Interest expense</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,427</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">4,587</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest (income)</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(309<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(680<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,118</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">3,907</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 2.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Depreciation of property, plant and equipment</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">5,183</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,731</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of intangible assets</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,449</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,528</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Amortization of other assets</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">59</td> <td style="border-bottom: #cceeff 1px solid; padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 348pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">6,644</td> <td style="padding-bottom: 0pt; padding-left: 5.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 17.25pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">6,318</td> <td style="padding-bottom: 0pt; padding-left: 8.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14"> </td> </tr> </table> <table style="width: 376pt; height: 88pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 7pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt;">Inventories</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Raw materials</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">57,719</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">54,861</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Work-in-process</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">12,014</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 24.75pt;">12,402</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 250pt; text-align: left; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Finished goods</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">101,195</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 24.75pt;">93,970</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">170,928</td> <td style="padding: 0pt 0pt 0pt 5.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 24.75pt;">161,233</td> <td style="padding: 0pt 0pt 0pt 8.145pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> <div style="color: #000000; text-transform: none; line-height: 12pt; text-indent: 40pt; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 13.49pt; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </div> <table style="width: 376pt; height: 130pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 1pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: left; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt;">Accrued expenses and other current liabilities</td> <td style="padding: 0pt; width: 6pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Employee related</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">21,030</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">26,553</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Commissions and rebates</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">4,964</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">6,443</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Insurance related</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">1,522</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">1,515</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Professional fees</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,513</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,823</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Income and other taxes</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,631</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 21pt;">3,035</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 2pt; width: 250pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="white-space: nowrap;">Other</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 21pt;">16,820</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 21pt;">11,283</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 21pt;">51,480</td> <td style="padding: 0pt 0pt 0pt 7.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 21pt;">52,652</td> <td style="padding: 0pt 0pt 0pt 10.645pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="height: 4.5pt; line-height: 4.5pt;"> <td style="padding: 0pt; line-height: 0pt; font-size: 0pt;" colspan="14"> </td> </tr> </table> <table style="width: 376pt; height: 166pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 13.33px; font-style: normal; font-weight: normal; margin-top: 13pt; margin-left: 40pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">As of</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="padding-right: 16pt; padding-bottom: 1pt; padding-left: 16pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="padding-right: 19pt; padding-bottom: 1pt; padding-left: 19pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">2017</font></div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 250pt; text-align: left;">Accumulated other comprehensive income (loss)</td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 0pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Derivative instruments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">2,064</td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">2,686</td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Foreign currency translation adjustment</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(40,323<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(43,556<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 250pt; text-align: left;"> <div style="white-space: nowrap;">Unrecognized net pension gains (losses)</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(17,928<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(18,059<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 250pt; text-align: left; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on derivative instruments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(1,316<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">(1,553<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 250pt; text-align: left; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for incomes taxes on long-term intercompany investments</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">8,166</td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 23.25pt;">8,166</td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 12pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 1.333pt; width: 250pt; text-align: left; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid; white-space: normal;"> <div style="text-indent: -10pt; margin-left: 10pt;">(Provision) benefit for income taxes on pension gains (losses)</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 23.25pt;">(3,171<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; min-width: 3.75pt;"> </td> <td style="padding: 1.667pt 0pt 1.333pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid; white-space: nowrap; min-width: 23.25pt;">(3,121<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #cceeff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 0.75pt; width: 250pt; text-align: left;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 23.25pt;">(52,508<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 5.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 2pt; text-align: right; border-bottom-color: #000000; border-bottom-width: 3px; border-bottom-style: double; white-space: nowrap; min-width: 23.25pt;">(55,437<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 8.98pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table>

<table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 33%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 117px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 19pt; padding-right: 19pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Term A Loan due June 2022</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">248,438</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">250,000</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Capitalized lease obligations</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">182</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">248,620</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">250,000</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Unamortized debt issuance costs and debt discount</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(1,766<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(1,859<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">246,854</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">248,141</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Less: current maturities</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(7,895<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(6,250<font style="position: absolute;">)</font></td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 0.75pt; padding-left: 0pt; width: 250pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">238,959</td> <td style="padding-bottom: 0pt; padding-left: 5.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">241,891</td> <td style="padding-bottom: 0pt; padding-left: 8.145pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14"> </td> </tr> </table>

<table style="width: 456pt; height: 63.5pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10.66px; font-style: normal; font-weight: normal; margin-top: 8pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="height: 14.25pt; text-align: center; color: #000000; text-transform: none; line-height: 8pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 2pt; width: 105.51pt; text-align: left;" rowspan="2"> <div style="line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">Instrument</font></div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 2pt; width: 80.51pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;">Hedge</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 2pt; width: 47.41pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt;">Notional <br />Amount at <br />September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 2pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="13"> <div style="text-align: center; white-space: nowrap;">Fair value as of</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="height: 0pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; width: 84.74pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="text-align: center;">Consolidated <br />Balance Sheet</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 6pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">June 30, <br />2017</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 2.75pt 0pt 1pt; width: 105.51pt; text-align: left;"> <div style="white-space: nowrap;">Options</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0.5pt 1pt 0pt; width: 80.51pt;"> <div style="text-align: right; white-space: nowrap;">Brazilian Real calls </div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; width: 47.41pt; text-align: center;"> <div style="text-align: center;">R$19,500</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; width: 84.74pt; text-align: left;"> <div style="white-space: nowrap;">Other current assets</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">1,781</td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 2.75pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 18.75pt;"> 2,686</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 3pt 0pt 1pt; width: 105.51pt; text-align: left;"> <div style="white-space: nowrap;">Swap</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0.5pt 1pt 0pt; width: 80.51pt;"> <div style="text-align: right;">Interest rate swap </div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0pt 1pt; width: 47.41pt; text-align: center;"> <div style="text-align: center;">$ 150,000</div> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 3pt 0pt 1pt; width: 84.74pt; text-align: left;">Other assets</td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 17.25pt;">283</td> <td style="padding: 0pt 0pt 0pt 9.85pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 6pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 3pt 0pt 1pt; text-align: right; min-width: 3.75pt;">$</td> <td style="padding: 3pt 0pt 1pt; text-align: right; white-space: nowrap; min-width: 18.75pt;"> —</td> <td style="padding: 0pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table> <table style="width: 456pt; height: 101pt; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman', times, serif; font-size: 10.66px; font-style: normal; font-weight: normal; margin-top: 11pt; word-spacing: 0px; white-space: normal; border-collapse: collapse; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> <tr style="height: 26.75pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt 0pt 1.667pt; width: 39pt; text-align: left;" rowspan="2"> <div style="line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;"><font style="padding-right: 1pt; padding-bottom: 1pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;">Instrument</font></div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 44pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> <div style="text-align: center; line-height: 9pt; padding-bottom: 0.333pt; white-space: nowrap;">Hedge</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;" rowspan="2"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Gain (loss) recorded in OCI</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="13"> <div style="text-align: center;">Gain (loss) recognized in <br />consolidated statements of operations</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt 0pt 1.667pt; width: 0pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="10"> <div style="text-align: center;">Consolidated Statement <br />of Operations Line <br />Item Total</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="height: 0pt; text-align: center; color: #000000; text-transform: none; line-height: 9pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: bold; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; width: 46.13pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;"> <div style="text-align: center;">Consolidated <br />Statement<br />of Operations</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2017</div> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 0pt; width: 2.65pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> <td style="padding: 2.083pt 0pt 1.667pt; border-bottom-color: #000000; border-bottom-width: 1px; border-bottom-style: solid;" colspan="4"> <div style="text-align: center;">September 30, <br />2016</div> </td> <td style="padding: 0pt; width: 0pt; border-bottom-color: #ffffff; border-bottom-width: 1px; border-bottom-style: solid;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; background-color: #cceeff; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.417pt 0pt 0.5pt; width: 39pt; text-align: left;"> <div style="white-space: nowrap;">Options</div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; width: 44pt; text-align: left;">Brazilian <br />Real calls</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">(905<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 7.5pt;">34</td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; width: 46.13pt; text-align: left;">Cost of <br />goods sold</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 9pt;">186</td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 15.75pt;">(1,135<font style="position: absolute;">)</font></td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">130,030</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.417pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">126,988</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> <tr style="text-align: right; color: #000000; text-transform: none; line-height: 10pt; font-family: 'times new roman', times, serif; font-size: 8pt; font-style: normal; font-weight: normal; vertical-align: bottom; white-space: nowrap; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding: 1.667pt 0pt 0.5pt; width: 39pt; text-align: left;"> <div style="white-space: nowrap;">Swap</div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.667pt 0.5pt 0.5pt 0pt; width: 44pt;"> <div style="text-align: right;">Interest rate<br />swap </div> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 11.25pt;">283</td> <td style="padding: 0pt 0pt 0pt 14.38pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 7.5pt;"> —</td> <td style="padding: 0pt 0pt 0pt 16.625pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; width: 46.13pt; text-align: left;">Interest <br />expense, net</td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 9pt;"> —</td> <td style="padding: 0pt 0pt 0pt 15.705pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 15.75pt;"> —</td> <td style="padding: 0pt 0pt 0pt 11.29pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">3,118</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt; width: 2.65pt;"> </td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; min-width: 3pt;">$</td> <td style="padding: 1.667pt 0pt 0.5pt; text-align: right; white-space: nowrap; min-width: 19.5pt;">3,907</td> <td style="padding: 0pt 0pt 0pt 8.62pt; width: 0pt;"> </td> <td style="padding: 0pt; width: 0pt;"> </td> </tr> </table>

<table style="widows: 2; text-transform: none; font-style: normal; margin-top: 7pt; text-indent: 0px; width: 33%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 75px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">September 30, 2017</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="16"> <div style="text-align: center; white-space: nowrap;">June 30, 2017</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 1</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 2</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;">Level 3</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Derivatives asset</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"> —</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">1,781</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"> —</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;"> —</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">2,686</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Interest rate swap</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">283</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 12pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 139.06pt; padding-right: 0pt; padding-top: 1.667pt;"> <div style="text-indent: -10pt; margin-left: 10pt;">Contingent consideration on <br />acquisitions</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">—</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(7,827<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 11.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">—</td> <td style="padding-bottom: 0pt; padding-left: 1.865pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 17.25pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 1.667pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 1.667pt;">(7,644<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> </table>

<table style="widows: 2; text-transform: none; font-style: normal; margin-top: 8pt; text-indent: 0px; width: 33%; border-collapse: collapse; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; height: 52px; color: #000000; margin-left: 40pt; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;" border="0"> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;"> </td> <td style="text-align: left; padding-bottom: 0.5pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;">Balance, June 30, 2017</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;">$</td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 0.5pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 0pt;">(7,644<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;"> </td> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Acquisition-related accrued interest</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 19.5pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">(253<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 3pt;"> <div style="white-space: nowrap;">Payment</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">70</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="width: 0pt; padding: 0pt;"> </td> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 332.96pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;">Balance, September 30, 2017</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 19.5pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">(7,827<font style="position: absolute;">)</font></td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="9"> </td> </tr> </table>

<table style="margin-top: 8pt; width: 38%; border-collapse: collapse; height: 453px;" border="0"> <tr style="text-align: left; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0.5pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; text-align: center; padding-bottom: 2pt; padding-left: 0pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="10"> <div style="text-align: center; white-space: nowrap;">Three Months</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: center; line-height: 8pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">For the Periods Ended September 30</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;" colspan="4"> <div style="text-align: center; white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 11pt; padding-right: 11pt;">2016</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;">Net sales</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">MFAs and other</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">79,603</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">83,419</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Nutritional Specialties</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">30,777</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">26,304</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Vaccines</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">18,461</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">14,778</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">128,841</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">124,501</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">52,073</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">51,592</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">12,498</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">11,894</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">193,412</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">187,987</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 8.25pt;">Depreciation and amortization</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">5,254</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">4,898</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">585</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">542</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">246</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">218</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">6,085</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">5,658</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 8.25pt;">Adjusted EBITDA</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">33,742</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">32,619</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,716</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,988</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #cceeff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">248</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">742</td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #cceeff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,706</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 8.25pt;">Reconciliation of income before income taxes to Adjusted EBITDA</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Income before income taxes</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">18,944</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">17,572</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Interest expense, net</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,118</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">3,907</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Depreciation and amortization – Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">6,085</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">5,658</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Depreciation and amortization – Corporate</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">559</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">660</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Corporate costs</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,589</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">7,524</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Acquisition-related cost of goods sold</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">249</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">—</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Acquisition-related accrued compensation</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">437</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">420</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Acquisition-related transaction costs</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">400</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">1,274</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 20pt;">Foreign currency (gains) losses, net</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">325</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">334</td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 356.59pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Adjusted EBITDA – Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,706</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">37,349</td> <td style="width: 0pt; padding: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14"> </td> </tr> </table> <div style="widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; break-after: page;"> <table style="margin-top: 10pt; width: 33%; border-collapse: collapse; height: 116px; margin-left: 40pt;" border="0"> <tr style="text-align: center; line-height: 9pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 8pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1.667pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 0pt;"> <div style="white-space: nowrap;"><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-right: 1pt;">As of</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">September 30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 16pt; padding-right: 16pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 1.667pt; padding-left: 0pt; padding-right: 0pt; padding-top: 0pt;" colspan="4"> <div style="text-align: center;">June 30,<br /><font style="border-bottom: #000000 1px solid; padding-bottom: 1pt; padding-left: 18pt; padding-right: 18pt;">2017</font></div> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: left; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: bold; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;">Identifiable assets</td> <td style="width: 6pt; padding: 0pt;"> </td> <td colspan="6"> </td> <td colspan="6"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Animal Health</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">479,075</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;">$</td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">442,521</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Mineral Nutrition</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">60,371</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">55,184</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Performance Products</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">22,331</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">23,681</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total segments</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">561,777</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="min-width: 3.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;"> </td> <td style="min-width: 24.75pt; text-align: right; padding-bottom: 1pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">521,386</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="border-bottom: #ffffff 1px solid; text-align: left; padding-bottom: 2pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 3pt;"> <div style="margin-left: 10pt;">Corporate</div> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">109,334</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 6pt; padding: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 3pt;"> </td> <td style="border-bottom: #000000 1px solid; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 3pt;">102,011</td> <td style="border-bottom: #ffffff 1px solid; padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #ffffff 1px solid; width: 0pt; padding: 0pt;"> </td> </tr> <tr style="text-align: right; line-height: 10pt; text-transform: none; background-color: #cceeff; font-style: normal; font-family: 'times new roman', times, serif; white-space: nowrap; color: #000000; font-size: 10pt; vertical-align: bottom; font-weight: normal; font-variant-ligatures: normal; font-variant-caps: normal;"> <td style="text-align: left; padding-bottom: 2.75pt; padding-left: 0pt; width: 252pt; padding-right: 0pt; padding-top: 2.75pt;"> <div style="margin-left: 10pt;">Total</div> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">671,111</td> <td style="padding-bottom: 0pt; padding-left: 4.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="width: 6pt; padding: 0pt;"> </td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="border-bottom: #000000 3px double; min-width: 3.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; padding-top: 2.75pt;">$</td> <td style="border-bottom: #000000 3px double; min-width: 24.75pt; text-align: right; padding-bottom: 2pt; padding-left: 0pt; padding-right: 0pt; white-space: nowrap; padding-top: 2.75pt;">623,397</td> <td style="padding-bottom: 0pt; padding-left: 7.645pt; width: 0pt; padding-right: 0pt; padding-top: 0pt;"> </td> <td style="width: 0pt; padding: 0pt;"> </td> </tr> <tr style="line-height: 4.5pt; height: 4.5pt;"> <td style="line-height: 0pt; font-size: 0pt; padding: 0pt;" colspan="14"> </td> </tr> </table> </div>

498000

349000

0.10

3989000

81000

239000

4587000

3427000

680000

309000

-3907000

3907000

-3118000

3118000

4731000

5183000

1528000

1449000

59000 12000

54861000

57719000

12402000

12014000

93970000

101195000

26553000

21030000

6443000

4964000

1515000

1522000

3823000

3513000

3035000

3631000

11283000

16820000

2686000 2064000 -43556000 -40323000 18059000 17928000 -1553000 -1316000 8166000 8166000 -3121000 -3171000

3719000

516000

3802000

559000

250000000

2.00%, 1.75% or 1.50%

1.00%, 0.75% or 0.50%

160349000

0.0298

0.0322

603000

720000

6822000

7211000

6898000

140

19500000

150000000

2686000

1781000

283000

-905000

1781000

2686000

1781000

7644000

7827000

70000 37349000 742000 32619000 3988000 37349000 37706000 248000 33742000 3716000 37706000

15000000

283000

0.018325

150000000 0001069899us-gaap:CapitalLeaseObligationsMember2017-06-30

248620000

250000000

-1766000

-1859000

246854000 248141000

7895000

6250000

238959000

241891000

250000000

0001069899us-gaap:EurodollarMemberpahc:TermALoansAndRevolvingCreditFacilityMemberpahc:CreditAgreementMember2017-07-012017-09-30

2.00%, 1.75% or 1.50%

85000000

0001069899us-gaap:RevolvingCreditFacilityMemberpahc:CreditAgreementMember2017-07-012017-09-30

4651000

0001069899us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:StockOptionMember2017-09-30

780000

0001069899pahc:TermALoansAndRevolvingCreditFacilityMemberpahc:CreditAgreementMember2017-09-30 0 0001069899us-gaap:OtherAssetsMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:SwapMember2017-09-30 0001069899us-gaap:OtherCurrentAssetsMemberus-gaap:LongMemberus-gaap:CashFlowHedgingMemberus-gaap:StockOptionMember2017-09-30 0001069899us-gaap:OtherComprehensiveIncomeMemberus-gaap:CashFlowHedgingMemberus-gaap:InterestRateSwapMemberus-gaap:SwapMember2017-07-012017-09-30

283000

0001069899us-gaap:OtherComprehensiveIncomeMemberus-gaap:LongMemberus-gaap:CashFlowHedgingMemberus-gaap:StockOptionMember2016-07-012016-09-30

34000

0001069899us-gaap:StockOptionMember us-gaap:LongMember us-gaap:CostOfSalesMember us-gaap:CashFlowHedgingMember 2016-07-012016-09-30

-1135000

0001069899us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:StockOptionMember2017-07-012017-09-30

2905000

955000

2033000

681000

0001069899us-gaap:OtherComprehensiveIncomeMemberus-gaap:CashFlowHedgingMemberus-gaap:StockOptionMember2017-09-30 1622000 966000

186000

0001069899us-gaap:CorporateNonSegmentMember2017-07-012017-09-30

559000

0001069899us-gaap:CorporateNonSegmentMember2016-07-012016-09-30

660000

7589000 7524000 249000

437000

420000

400000 1274000 3500000

248438000

250000000

182000

EX-101.SCH 7 pahc-20170930.xsd XBRL SCHEMA FILE 001 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) (unaudited) link:presentationLink link:definitionLink link:calculationLink 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Description of Business link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Statements of Operations-Additional Information link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Balance Sheets-Additional Information link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Employee Benefit Plans link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Derivatives link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Business Segments link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Statements of Operations-Additional Information (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Balance Sheets-Additional Information (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Derivatives (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Business Segments (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Statements of Operations-Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Balance Sheets-Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Balance Sheets-Additional Information (Details 1) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Balance Sheets-Additional Information (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Debt - Summary of long-term debt (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Debt (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Related Party Transactions (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Employee Benefit Plans (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Commitments and Contingencies (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Derivatives (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Derivatives (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Business Segments (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Business Segments (Detail Textuals) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Derivatives (Details 1) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 pahc-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 pahc-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 pahc-20170930_lab.xml XBRL LABEL FILE Document And Entity Information [Abstract] Statement [Table] Class of Stock [Axis] Class of Stock [Domain] Common Class A [Member] Common stock-Class A Class A common stock Common Class B [Member] Common stock-Class B Class B common stock Statement [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Trading Symbol Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Income Statement [Abstract] Revenues Total net sales Net sales Total sales Cost of Goods Sold Cost of goods sold Cost of goods sold Consolidated Statement of Operations Line Item Total Gross Profit Gross profit Gross profit Selling, General and Administrative Expense Selling, general and administrative expenses Operating Income (Loss) Operating income Operating income (loss) Operating income Operating income Interest Income (Expense), Net, Total Interest expense, net Interest expense, net Interest expense Interest expense, net Foreign Currency Transaction Gain (Loss), before Tax Foreign currency (gains) losses, net Foreign currency (gains) losses, net Foreign currency (gains) losses, net Foreign currency (gains) losses, net Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Income before income taxes Income before income taxes Income before income taxes Income Tax Expense (Benefit) Income tax benefit Provision (benefit) for income taxes Provision (benefit) for income taxes Net Income (Loss) Attributable to Parent Net income Net income Net income Net income Earnings Per Share [Abstract] Net income per share Net income per share Earnings Per Share, Basic basic (in dollars per share) basic (in dollars per share) Earnings Per Share, Diluted diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares - basic (in shares) basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares - diluted diluted (in shares) Weighted average number of shares - diluted (in shares) Common Stock, Dividends, Per Share, Declared Dividends per share (in dollars per share) Statement of Comprehensive Income [Abstract] Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax, Portion Attributable to Parent, Total Fair value of derivative instruments, net of income taxes Change in fair value of derivative instruments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent, Total Foreign currency translation adjustment Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax, Portion Attributable to Parent, Total Net change Unrecognized net pension gains (losses) Unrecognized net pension gains (losses) Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent (Provision) benefit for income taxes (Provision) benefit for income taxes Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive income (loss) Comprehensive income Statement of Financial Position [Abstract] Assets [Abstract] ASSETS Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash and cash equivalents at end of period Accounts Receivable, Net, Current Accounts receivable, net Inventory, Net Inventories, net Inventories Inventory, net Other Assets, Current Other current assets Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property, plant and equipment, net Property, plant and equipment, net Finite-Lived Intangible Assets, Net Intangibles, net Intangibles, net Goodwill Goodwill Goodwill Balance at beginning of period Balance at end of period Other Assets, Noncurrent Other assets, total Other assets Other assets, total Assets Identifiable assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) LIABILITIES AND STOCKHOLDERS' EQUITY Long-term Debt, Current Maturities Current portion of long-term debt Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses and other current liabilities Accrued expenses and other current liabilities, total Liabilities, Current Total current liabilities Long-term Line of Credit, Noncurrent Outstanding borrowings Revolving credit facility Long-term Debt and Capital Lease Obligations Long-term debt Long-term debt Other Liabilities, Noncurrent Other liabilities Other liabilities, total Other liabilities, total Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 8) Common Stock, Value, Outstanding Common stock, par value $0.0001; 300,000,000 Class A shares authorized, 18,519,757 and 17,747,793 shares issued and outstanding at June 30, 2016 and June 30, 2015, respectively; 30,000,000 Class B shares authorized, 20,887,811 and 21,320,275 shares issued and outstanding at June 30, 2016 and June 30, 2015, respectively Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 19,555,839 and 19,249,132 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively; 30,000,000 Class B shares authorized, 20,614,836 and 20,626,836 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively Preferred Stock, Value, Outstanding Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding Preferred stock, par value $0.0001; 16,000,000 shares authorized, no shares issued and outstanding Additional Paid in Capital, Common Stock Paid-in capital Accumulated deficit Retained earnings (accumulated deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) Accumulated other comprehensive income (loss) Stockholders' Equity Attributable to Parent Total shareholders' equity (deficit) Total stockholders' equity Balance Balance Liabilities and Equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Net issuance of common stock Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Preferred Stock, Par or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] OPERATING ACTIVITIES Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided (used) by operating activities: Adjustments to reconcile net income to net cash provided (used) by operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Depreciation and amortization Depreciation and amortization Amortization of Financing Costs and Discounts, Total Amortization of debt issuance costs and debt discount Amortization of debt issuance costs and debt discount Acquisition Related Cost Of Goods Sold Acquisition-related cost of goods sold Represents acquisition costs related to inventory impacting cost of goods sold. Business Combination, Acquisition Related Costs Acquisition related compensation expense Acquisition-related accrued compensation Acquisition-related accrued compensation Accretion Expense Acquisition-related accrued interest Acquisition-related accrued interest Deferred Income Tax Expense (Benefit) Total deferred tax provision Deferred income taxes Total deferred provision Foreign Currency Transaction Gain (Loss), Unrealized Foreign currency (gains) losses, net Foreign currency (gains) losses, net Other Noncash Income (Expense) Other Other Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities, net of business acquisition: Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Accounts receivable, net Increase (Decrease) in Inventories Inventories Inventories, net Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Other current assets Increase (Decrease) in Other Noncurrent Assets Other assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided (used) by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] INVESTING ACTIVITIES Payments to Acquire Productive Assets Capital expenditures Capital expenditures Payments to Acquire Businesses, Gross Business acquisition Business acquisition Payments for (Proceeds from) Other Investing Activities Asset sales Other, net Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash provided (used) by investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] FINANCING ACTIVITIES Proceeds from Long-term Lines of Credit Revolving credit facility borrowings Borrowings under the revolving and domestic senior credit facility Repayments of Long-term Lines of Credit Repayments of the revolving and domestic senior credit facility Revolving credit facility repayments Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Payments of long-term debt and capital leases Payments of long-term debt, capital leases and other Proceeds from Issuance of Common Stock Proceeds from common shares issued Payments of Dividends Dividends paid Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided (used) by financing activities Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Effect of exchange rate changes on cash Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Description Of Business [Abstract] Nature of Operations [Text Block] Description of Business Accounting Policies [Abstract] Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Summary of Significant Accounting Policies and New Accounting Standards Supplemental Income Statement Elements [Abstract] Additional Financial Information Disclosure [Text Block] Statements of Operations-Additional Information Balance Sheets Additional Information [Abstract] Supplemental Balance Sheet Disclosures [Text Block] Balance Sheets-Additional Information Debt Disclosure [Abstract] Debt Disclosure [Text Block] Debt Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Compensation and Retirement Disclosure [Abstract] Compensation and Employee Benefit Plans [Text Block] Employee Benefit Plans Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Text Block] Derivatives Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Business Segments Earnings Per Share, Policy [Policy Text Block] Net Income per Share and Weighted Average Shares Dividend Policy [Policy Text Block] Dividends Disclosure of dividend policy. New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Standards Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Net Income per Share and Weighted Average Shares Schedule Of Additional Information Of Statements Of Operations [Table Text Block] Schedule of additional information of statements of operations Tabular disclosure of additional Information of statements of operations. Schedule Of Additional Information Of Balance Sheets [Table Text Block] Schedule of additional information of balance sheets Tabular disclosure of additional Information of balance sheets. Schedule of Long-term Debt Instruments [Table Text Block] Schedule of long term debt Schedule of Derivative Instruments [Table Text Block] Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of fair value derivatives, assets and liabilities Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Schedule of changes in the fair value of Level 3 assets Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of information regarding reportable segments Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants Dilutive effect of stock options Earnings Per Share, Basic and Diluted [Abstract] Net income per share Net income (loss) per share: Common Stock, Dividends, Per Share, Cash Paid Cash dividends per share amount (in dollars per share) Payments of Ordinary Dividends, Common Stock Cash dividends Statements Of Operations Additional Information [Abstract] Statements Of Operations Additional Information [Table] Schedule of Statements of Operations Additional Information. Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Revolving Credit Facility [Member] Revolving credit facility (the "Revolver") Revolving credit facility Credit Facility [Axis] Credit Facility [Domain] Term B Loans [Member] Term A Loan due June 2022 Term loan Represents information about Term A loans. Statements Of Operations Additional Information [Line Items] Line item represents Statements of Operations Additional Information. Interest Expense [Abstract] Interest expense, net Interest Expense, Other Other Interest Expense, Debt Interest expense Interest expense Interest expense Interest expense Interest and Other Income Interest (income) Interest (income) Interest Income (Expense), Nonoperating, Net Interest expense, net Interest expense, net Interest expense, net Depreciation, Depletion and Amortization [Abstract] Depreciation and amortization Depreciation Depreciation of property, plant and equipment Amortization of Intangible Assets Amortization of intangible assets Amortization of intangibles Amortization Of Other Assets Amortization of other assets Represents amortization of other assets. Inventory, Net [Abstract] Inventories Inventories Inventory, Raw Materials, Net of Reserves Raw materials Inventory, Work in Process, Net of Reserves Work-in-process Inventory, Finished Goods, Net of Reserves Finished goods Accrued Liabilities and Other Liabilities [Abstract] Accrued expenses and other current liabilities Employee-related Liabilities, Current Employee related Accrued Sales Commission, Current Commissions and rebates Accrued Insurance, Current Insurance related Insurance premiums and casualty claims Accrued Professional Fees, Current Professional fees Taxes Payable, Current Income and other taxes Other Liabilities, Current Other Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Accumulated other comprehensive income (loss) Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments (Provision) benefit for income taxes on derivative instruments Accumulated amount of Income tax (provision) benefit on derivative instruments. Income Tax Provision Benefit On Long Term Intercompany Loans (Provision) benefit for incomes taxes on long-term intercompany investments Income tax (provision) benefit on long-term intercompany loans. (Provision) benefit for incomes taxes on long-term intercompany investments Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses (Provision) benefit for income taxes on pension gains (losses) accumulated amount of income tax (provision) benefit on pension gains (losses). (Provision) benefit for income taxes on pension gains (losses) Equity Method Investments Equity method investments Equity method investments Business Combination, Consideration Transferred Amount of acquired business approximately Schedule of Long-term Debt Instruments [Table] Capital Lease Obligations [Member] Capitalized lease obligations Debt Instrument [Line Items] Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Unamortized debt issuance costs and debt discount Unamortized debt issuance costs and debt discount Long-term Debt and Capital Lease Obligations, Current Less: current maturities Less: current maturities Term A Loans And Revolving Credit Facility [Member] Term A Loan and together with the Revolver, "Credit Facilities" Represents information related to term A loans and revolving credit facility. EX-101.PRE 11 pahc-20170930_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Sep. 30, 2017	Oct. 30, 2017
Entity Registrant Name	PHIBRO ANIMAL HEALTH CORP
Entity Central Index Key	0001069899
Trading Symbol	pahc
Current Fiscal Year End Date	--06-30
Entity Filer Category	Accelerated Filer
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Amendment Flag	false
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q1
Class A common stock
Entity Common Stock, Shares Outstanding		19,581,889
Class B common stock
Entity Common Stock, Shares Outstanding		20,602,836

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Income Statement [Abstract]
Net sales	$ 193,412	$ 187,987
Cost of goods sold	130,030	126,988
Gross profit	63,382	60,999
Selling, general and administrative expenses	40,995	39,186
Operating income	22,387	21,813
Interest expense, net	3,118	3,907
Foreign currency (gains) losses, net	325	334
Income before income taxes	18,944	17,572
Provision (benefit) for income taxes	3,052	5,395
Net income	$ 15,892	$ 12,177
Net income per share
basic (in dollars per share)	$ 0.40	$ 0.31
diluted (in dollars per share)	$ 0.39	$ 0.31
Weighted average common shares outstanding
basic (in shares)	39,944	39,408
diluted (in shares)	40,293	39,906
Dividends per share (in dollars per share)	$ 0.10	$ 0.10

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Statement of Comprehensive Income [Abstract]
Net income	$ 15,892	$ 12,177
Change in fair value of derivative instruments	(622)	34
Foreign currency translation adjustment	3,233	(893)
Unrecognized net pension gains (losses)	131	7,169
(Provision) benefit for income taxes	187	(2,750)
Other comprehensive income (loss)	2,929	3,560
Comprehensive income	$ 18,821	$ 15,737

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
ASSETS
Cash and cash equivalents	$ 62,097	$ 56,083
Accounts receivable, net	136,337	125,847
Inventories, net	170,928	161,233
Other current assets	25,193	20,502
Total current assets	394,555	363,665
Property, plant and equipment, net	131,242	127,351
Intangibles, net	64,457	54,602
Goodwill	23,982	23,982
Other assets	56,875	53,797
Total assets	671,111	623,397
LIABILITIES AND STOCKHOLDERS' EQUITY
Current portion of long-term debt	7,895	6,250
Accounts payable	61,732	56,894
Accrued expenses and other current liabilities	51,480	52,652
Total current liabilities	121,107	115,796
Revolving credit facility	85,000	65,000
Long-term debt	238,959	241,891
Other liabilities	56,570	49,553
Total liabilities	501,636	472,240
Commitments and contingencies (Note 8)
Common stock, par value $0.0001 per share; 300,000,000 Class A shares authorized, 19,555,839 and 19,249,132 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively; 30,000,000 Class B shares authorized, 20,614,836 and 20,626,836 shares issued and outstanding at September 30, 2017, and June 30, 2017, respectively	4	4
Preferred stock, par value $0.0001 per share; 16,000,000 shares authorized, no shares issued and outstanding
Paid-in capital	127,326	123,840
Retained earnings	94,653	82,750
Accumulated other comprehensive income (loss)	(52,508)	(55,437)
Total stockholders' equity	169,475	151,157
Total liabilities and stockholders' equity	$ 671,111	$ 623,397

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parentheticals) (unaudited) - $ / shares	Sep. 30, 2017	Jun. 30, 2017
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	16,000,000	16,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	19,555,839	19,249,132
Common stock, shares outstanding	19,555,839	19,249,132
Class B common stock
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	30,000,000	30,000,000
Common stock, shares issued	20,614,836	20,626,836
Common stock, shares outstanding	20,614,836	20,626,836

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES
Net income	$ 15,892	$ 12,177
Adjustments to reconcile net income to net cash provided (used) by operating activities:
Depreciation and amortization	6,644	6,318
Amortization of debt issuance costs and debt discount	221	253
Acquisition-related cost of goods sold	249
Acquisition-related accrued compensation	437	420
Acquisition-related accrued interest	253	393
Deferred income taxes	770	1,706
Foreign currency (gains) losses, net	345	97
Other	213	87
Changes in operating assets and liabilities, net of business acquisition:
Accounts receivable, net	(8,386)	3,906
Inventories, net	(5,196)	4,544
Other current assets	(4,458)	(2,430)
Other assets	332	346
Accounts payable	3,652	(5,004)
Accrued expenses and other liabilities	(6,165)	(1,357)
Net cash provided (used) by operating activities	4,803	21,456
INVESTING ACTIVITIES
Capital expenditures	(4,998)	(5,911)
Business acquisition	(11,562)
Other, net	(272)	25
Net cash provided (used) by investing activities	(16,832)	(5,886)
FINANCING ACTIVITIES
Revolving credit facility borrowings	61,870	34,000
Revolving credit facility repayments	(41,870)	(41,000)
Payments of long-term debt, capital leases and other	(1,652)	(729)
Proceeds from common shares issued	3,486
Dividends paid	(3,989)	(3,941)
Net cash provided (used) by financing activities	17,845	(11,670)
Effect of exchange rate changes on cash	198	(90)
Net increase (decrease) in cash and cash equivalents	6,014	3,810
Cash and cash equivalents at beginning of period	56,083	33,605
Cash and cash equivalents at end of period	$ 62,097	$ 37,415

XML 18 R7.htm IDEA: XBRL DOCUMENT

Description of Business	3 Months Ended
Description of Business	Sep. 30, 2017
Description Of Business [Abstract]
Description of Business	1. Description of Business Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, swine, cattle, dairy and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries. The unaudited consolidated financial information for the three months ended September 30, 2017 and 2016, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2017 (the “Annual Report”), filed with the Securities and Exchange Commission on August 30, 2017 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2017, was derived from the audited consolidated financial statements, which include the accounts of Phibro and its consolidated subsidiaries, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report. The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated in the consolidated financial statements. The decision whether or not to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards

3 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies and New Accounting Standards

2. Summary of Significant Accounting Policies and New Accounting Standards

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.

	Three Months
For the Periods Ended September 30	2017			2016
Net income		$	15,892		$	12,177
Weighted average number of shares – basic			39,944			39,408
Dilutive effect of stock options			349			498
Weighted average number of shares – diluted			40,293			39,906
Net income per share
basic		$	0.40		$	0.31
diluted		$	0.39		$	0.31

Dividends

We declared and paid quarterly cash dividends of $0.10 per share, totaling $3,989 during the three months ended September 30, 2017, to holders of our Class A common stock and Class B common stock.

New Accounting Standards

XML 20 R9.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information

3 Months Ended

Sep. 30, 2017

Supplemental Income Statement Elements [Abstract]

Statements of Operations-Additional Information

3. Statements of Operations—Additional Information

	Three Months
For the Periods Ended September 30	2017			2016
Interest expense, net
Term loan		$	2,033		$	2,905
Revolving credit facility			681			955
Amortization of debt issuance costs and debt discount			221			253
Acquisition-related accrued interest			253			393
Other			239			81
Interest expense			3,427			4,587
Interest (income)			(309)			(680)
		$	3,118		$	3,907
Depreciation and amortization
Depreciation of property, plant and equipment		$	5,183		$	4,731
Amortization of intangible assets			1,449			1,528
Amortization of other assets			12			59
		$	6,644		$	6,318

XML 21 R10.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information

3 Months Ended

Sep. 30, 2017

Balance Sheets Additional Information [Abstract]

Balance Sheets-Additional Information

4. Balance Sheets—Additional Information

As of	September 30, 2017			June 30, 2017
Inventories
Raw materials		$	57,719		$	54,861
Work-in-process			12,014			12,402
Finished goods			101,195			93,970
		$	170,928		$	161,233

Goodwill balances did not change during the three months ended September 30, 2017.

As of	September 30, 2017			June 30, 2017
Accrued expenses and other current liabilities
Employee related		$	21,030		$	26,553
Commissions and rebates			4,964			6,443
Insurance related			1,522			1,515
Professional fees			3,513			3,823
Income and other taxes			3,631			3,035
Other			16,820			11,283
		$	51,480		$	52,652

As of	September 30, 2017			June 30, 2017
Accumulated other comprehensive income (loss)
Derivative instruments		$	2,064		$	2,686
Foreign currency translation adjustment			(40,323)			(43,556)
Unrecognized net pension gains (losses)			(17,928)			(18,059)
(Provision) benefit for income taxes on derivative instruments			(1,316)			(1,553)
(Provision) benefit for incomes taxes on long-term intercompany investments			8,166			8,166
(Provision) benefit for income taxes on pension gains (losses)			(3,171)			(3,121)
		$	(52,508)		$	(55,437)

XML 22 R11.htm IDEA: XBRL DOCUMENT

Debt

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Debt

5. Debt

Term Loans and Revolving Credit Facilities

The weighted-average interest rates for the Revolver and Term A Loan were 2.98% and 3.22%, respectively, for the three months ended September 30, 2017.

In July 2017, we entered into an interest rate swap agreement on $150 million of notional principal that effectively converts the floating LIBOR or base rate portion of our interest obligation on that amount of debt, to a fixed interest rate of 1.8325% plus the applicable rate. The agreement matures concurrent with the Credit Agreement. The interest rate swap has been designated as a highly effective cash flow hedge. For additional details, see “—Derivatives.”

Long-Term Debt

As of	September 30, 2017			June 30, 2017
Term A Loan due June 2022		$	248,438		$	250,000
Capitalized lease obligations			182			—
			248,620			250,000
Unamortized debt issuance costs and debt discount			(1,766)			(1,859)
			246,854			248,141
Less: current maturities			(7,895)			(6,250)
		$	238,959		$	241,891

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Sep. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	6. Related Party Transactions Certain relatives of Jack C. Bendheim, our Chairman, President and Chief Executive Officer, provided services to us as employees or consultants and received aggregate compensation and benefits of approximately $720 and $603 during the three months ended September 30, 2017 and 2016. Mr. Bendheim has sole authority to vote shares of our stock owned by BFI Co., LLC, an investment vehicle of the Bendheim family.

XML 24 R13.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans	3 Months Ended
Employee Benefit Plans	Sep. 30, 2017
Compensation and Retirement Disclosure [Abstract]
Employee Benefit Plans	7. Employee Benefit Plans The Company maintains a noncontributory defined benefit pension plan for all domestic nonunion employees employed on or prior to December 31, 2013, who meet certain requirements of age, length of service and hours worked per year. Plan benefits are based upon years of service and average compensation, as defined. In July 2016, we amended the domestic noncontributory defined benefit pension plan to eliminate credit for future service and compensation increases, effective as of September 30, 2016. The amendment resulted in a curtailment of the pension plan. During the three months ended September 30, 2016, we recorded a pension curtailment gain of $6,822 in other comprehensive income and an offsetting reduction in the liability for pension benefits included in other liabilities.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Sep. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Environmental Our operations and properties are subject to extensive federal, state, local and foreign laws and regulations, including those governing pollution; protection of the environment; the use, management, and release of hazardous materials, substances and wastes; air emissions; greenhouse gas emissions; water use, supply and discharges; the investigation and remediation of contamination; the manufacture, distribution, and sale of regulated materials, including pesticides; the importing, exporting and transportation of products; and the health and safety of our employees (collectively, “Environmental Laws”). As such, the nature of our current and former operations exposes us to the risk of claims with respect to such matters, including fines, penalties, and remediation obligations that may be imposed by regulatory authorities. Under certain circumstances, we might be required to curtail operations until a particular problem is remedied. Known costs and expenses under Environmental Laws incidental to ongoing operations, including the cost of litigation proceedings relating to environmental matters, are included within operating results. Potential costs and expenses may also be incurred in connection with the repair or upgrade of facilities to meet existing or new requirements under Environmental Laws or to investigate or remediate potential or actual contamination and from time to time we establish reserves for such contemplated investigation and remediation costs. In many instances, the ultimate costs under Environmental Laws and the time period during which such costs are likely to be incurred are difficult to predict. While we believe that our operations are currently in material compliance with Environmental Laws, we have, from time to time, received notices of violation from governmental authorities, and have been involved in civil or criminal action for such violations. Additionally, at various sites, our subsidiaries are engaged in continuing investigation, remediation and/or monitoring efforts to address contamination associated with historic operations of the sites. We devote considerable resources to complying with Environmental Laws and managing environmental liabilities. We have developed programs to identify requirements under, and maintain compliance with Environmental Laws; however, we cannot predict with certainty the effect of increased and more stringent regulation on our operations, future capital expenditure requirements, or the cost of compliance. The nature of our current and former operations exposes us to the risk of claims with respect to environmental matters and we cannot assure we will not incur material costs and liabilities in connection with such claims. Based upon our experience to date, we believe that the future cost of compliance with existing Environmental Laws, and liabilities for known environmental claims pursuant to such Environmental Laws, will not have a material adverse effect on our financial position, results of operations, cash flows or liquidity. The United States Environmental Protection Agency (the “EPA”) is investigating and planning for the remediation of offsite contaminated groundwater that has migrated from the Omega Chemical Corporation Superfund Site (“Omega Chemical Site”), which is upgradient of a facility in Santa Fe Springs, California, operated by our subsidiary Phibro-Tech, Inc. (“Phibro-Tech”). The EPA has named Phibro-Tech and certain other subsidiaries of PAHC as potentially responsible parties (“PRPs”) due to groundwater contamination from Phibro-Tech’s Santa Fe Springs facility that has allegedly commingled with contaminated groundwater from the Omega Chemical Site. In September 2012, the EPA notified approximately 140 PRPs, including Phibro-Tech and the other subsidiaries, that they have been identified as potentially responsible for remedial action for the groundwater plume affected by the Omega Chemical Site and for EPA oversight and response costs. Phibro-Tech contends that groundwater contamination at its site is due to historical operations that pre-date Phibro-Tech and/or contaminated groundwater that has migrated from upgradient properties. In addition, a successor to a prior owner of the Phibro-Tech site has asserted that PAHC and Phibro-Tech are obligated to provide indemnification for its potential liability and defense costs relating to the groundwater plume affected by the Omega Chemical Site. Phibro-Tech has vigorously contested this position and has asserted that the successor to the prior owner is required to indemnify Phibro-Tech for its potential liability and defense costs. Furthermore, a nearby property owner has filed a complaint in the Superior Court of the State of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for alleged contamination of groundwater underneath its property, and a group of companies that sent chemicals to the Omega Chemical Site for processing and recycling has filed a complaint under CERCLA, RCRA and the common law public nuisance doctrine in the United States District Court for the Central District of California against many of the PRPs allegedly associated with the groundwater plume affected by the Omega Chemical Site (including Phibro-Tech) for contribution toward past and future costs associated with the investigation and remediation of the groundwater plume affected by the Omega Chemical Site. Due to the ongoing nature of the EPA’s investigation and Phibro-Tech’s dispute with the prior owner’s successor, at this time we cannot predict with any degree of certainty what, if any, liability Phibro-Tech or the other subsidiaries may ultimately have for investigation, remediation and the EPA oversight and response costs associated with the affected groundwater plume. Based upon information available, to the extent such costs can be estimated with reasonable certainty, we estimated the cost for further investigation and remediation of identified soil and groundwater problems at operating sites, closed sites and third-party sites, and closure costs for closed sites, to be approximately $6,898 and $7,211 at September 30, 2017, and June 30, 2017, respectively, which is included in current and long-term liabilities on the consolidated balance sheets. However, future events, such as new information, changes in existing Environmental Laws or their interpretation, and more vigorous enforcement policies of regulatory agencies, may give rise to additional expenditures or liabilities that could be material. For all purposes of the discussion under this caption and elsewhere in this report, it should be noted that we take and have taken the position that neither PAHC nor any of our subsidiaries is liable for environmental or other claims made against one or more of our other subsidiaries or for which any of such other subsidiaries may ultimately be responsible. Claims and Litigation PAHC and its subsidiaries are party to a number of claims and lawsuits arising out of the normal course of business including product liabilities, payment disputes and governmental regulation. Certain of these actions seek damages in various amounts. In many cases, such claims are covered by insurance. We believe that none of the claims or pending lawsuits, either individually or in the aggregate, will have a material adverse effect on our financial position, results of operations, cash flows or liquidity.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Derivatives

3 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

9. Derivatives

We record derivatives at fair value in the consolidated balance sheets. For additional details regarding fair value, see “—Fair Value Measurements.”

The following tables detail the Company’s outstanding derivatives that are designated and effective as cash flow hedges as of September 30, 2017:

Instrument

Hedge

Notional
Amount at
September 30,
2017

Fair value as of

Consolidated
Balance Sheet

September 30,
2017

June 30,
2017

Options

Brazilian Real calls

R$19,500

Other current assets

1,781

2,686

Swap

Interest rate swap

$ 150,000

Other assets

283

—

Instrument	Hedge	Gain (loss) recorded in OCI						Gain (loss) recognized in consolidated statements of operations							Consolidated Statement of Operations Line Item Total
Instrument	Hedge	September 30, 2017			September 30, 2016			Consolidated Statement of Operations	September 30, 2017			September 30, 2016			September 30, 2017			September 30, 2016
Options	Brazilian Real calls		$	(905)		$	34	Cost of goods sold		$	186		$	(1,135)		$	130,030		$	126,988
Swap	Interest rate swap		$	283		$	—	Interest expense, net		$	—		$	—		$	3,118		$	3,907

The foreign currency derivatives generally have an expiration or maturity of two years or less and are intended to hedge cash flows related to the purchase of inventory. These forecasted transactions are probable of occurring. As the hedged item is sold, we recognize the gain or loss recorded in accumulated other comprehensive income (loss) to the consolidated statements of operations on the same line where the hedged item is charged when released/sold. The fair values of the foreign currency options as of September 30, 2017, are unrealized and will fluctuate based on future exchange rates until the derivative contracts mature. Accumulated other comprehensive income (loss) at September 30, 2017 included $1,781 of net unrecognized gains on derivative instruments; we estimate the entire amount will be recognized in earnings within the next twelve months. At September 30, 2017, realized gains of $1,622 related to matured contracts were recorded as a component of inventory. We anticipate these gains will be recognized as an offset to cost of goods sold within the next twelve months. At June 30, 2017, net realized gains of $966 related to matured contracts were recorded as a component of inventory. We recognized $186 of these gains in cost of goods sold during the three months September 30, 2017, and anticipate we will recognize the remaining $780 of these gains in costs of goods sold in the next six months. We recognize gains (losses) related to these derivative instruments as a component of cost of goods sold at the time the hedged item is sold.

XML 27 R16.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

10. Fair Value Measurements

Contingent Consideration on Acquisitions

Derivatives

Fair Value of Assets (Liabilities)

As of	September 30, 2017									June 30, 2017
	Level 1			Level 2			Level 3			Level 1			Level 2			Level 3
Derivatives asset		$	—		$	1,781		$	—		$	—		$	2,686		$	—
Interest rate swap		$	—		$	283		$	—		$	—		$	—		$	—
Contingent consideration on acquisitions		$	—		$	—		$	(7,827)		$	—		$	—		$	(7,644)

The table below provides a summary of the changes in the fair value of Level 3 assets (liabilities):

Balance, June 30, 2017	$	(7,644)
Acquisition-related accrued interest		(253)
Payment		70
Balance, September 30, 2017	$	(7,827)

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

Business Segments

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Business Segments

11. Business Segments

The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

	Three Months
For the Periods Ended September 30	2017			2016
Net sales
MFAs and other		$	79,603		$	83,419
Nutritional Specialties			30,777			26,304
Vaccines			18,461			14,778
Animal Health			128,841			124,501
Mineral Nutrition			52,073			51,592
Performance Products			12,498			11,894
Total segments		$	193,412		$	187,987
Depreciation and amortization
Animal Health		$	5,254		$	4,898
Mineral Nutrition			585			542
Performance Products			246			218
Total segments		$	6,085		$	5,658
Adjusted EBITDA
Animal Health		$	33,742		$	32,619
Mineral Nutrition			3,716			3,988
Performance Products			248			742
Total segments		$	37,706		$	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes		$	18,944		$	17,572
Interest expense, net			3,118			3,907
Depreciation and amortization – Total segments			6,085			5,658
Depreciation and amortization – Corporate			559			660
Corporate costs			7,589			7,524
Acquisition-related cost of goods sold			249			—
Acquisition-related accrued compensation			437			420
Acquisition-related transaction costs			400			1,274
Foreign currency (gains) losses, net			325			334
Adjusted EBITDA – Total segments		$	37,706		$	37,349

As of	September 30, 2017			June 30, 2017
Identifiable assets
Animal Health		$	479,075		$	442,521
Mineral Nutrition			60,371			55,184
Performance Products			22,331			23,681
Total segments			561,777			521,386
Corporate			109,334			102,011
Total		$	671,111		$	623,397

XML 29 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Policies)

3 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Net Income per Share and Weighted Average Shares

Basic net income per share is calculated by dividing net income by the weighted average number of common shares outstanding during the reporting period.

	Three Months
For the Periods Ended September 30	2017			2016
Net income		$	15,892		$	12,177
Weighted average number of shares – basic			39,944			39,408
Dilutive effect of stock options			349			499
Weighted average number of shares – diluted			40,293			39,906
Net income per share
basic		$	0.40		$	0.31
diluted		$	0.39		$	0.31

Dividends

We declared and paid quarterly cash dividends of $0.10 per share, totaling $3,989 during the three months ended September 30, 2017, to holders of our Class A common stock and Class B common stock.

New Accounting Standards

XML 30 R19.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Tables)

3 Months Ended

Sep. 30, 2017

Accounting Policies [Abstract]

Schedule of Net Income per Share and Weighted Average Shares

	Three Months
For the Periods Ended September 30	2017			2016
Net income		$	15,892		$	12,177
Weighted average number of shares – basic			39,944			39,408
Dilutive effect of stock options			349			498
Weighted average number of shares – diluted			40,293			39,906
Net income per share
basic		$	0.40		$	0.31
diluted		$	0.39		$	0.31

XML 31 R20.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information (Tables)

3 Months Ended

Sep. 30, 2017

Supplemental Income Statement Elements [Abstract]

Schedule of additional information of statements of operations

	Three Months
For the Periods Ended September 30	2017			2016
Interest expense, net
Term loan		$	2,033		$	2,905
Revolving credit facility			681			955
Amortization of debt issuance costs and debt discount			221			253
Acquisition-related accrued interest			253			393
Other			239			81
Interest expense			3,427			4,587
Interest (income)			(309)			(680)
		$	3,118		$	3,907
Depreciation and amortization
Depreciation of property, plant and equipment		$	5,183		$	4,731
Amortization of intangible assets			1,449			1,528
Amortization of other assets			12			59
		$	6,644		$	6,318

XML 32 R21.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information (Tables)

3 Months Ended

Sep. 30, 2017

Balance Sheets Additional Information [Abstract]

Schedule of additional information of balance sheets

As of	September 30, 2017			June 30, 2017
Inventories
Raw materials		$	57,719		$	54,861
Work-in-process			12,014			12,402
Finished goods			101,195			93,970
		$	170,928		$	161,233

As of	September 30, 2017			June 30, 2017
Accrued expenses and other current liabilities
Employee related		$	21,030		$	26,553
Commissions and rebates			4,964			6,443
Insurance related			1,522			1,515
Professional fees			3,513			3,823
Income and other taxes			3,631			3,035
Other			16,820			11,283
		$	51,480		$	52,652

As of	September 30, 2017			June 30, 2017
Accumulated other comprehensive income (loss)
Derivative instruments		$	2,064		$	2,686
Foreign currency translation adjustment			(40,323)			(43,556)
Unrecognized net pension gains (losses)			(17,928)			(18,059)
(Provision) benefit for income taxes on derivative instruments			(1,316)			(1,553)
(Provision) benefit for incomes taxes on long-term intercompany investments			8,166			8,166
(Provision) benefit for income taxes on pension gains (losses)			(3,171)			(3,121)
		$	(52,508)		$	(55,437)

XML 33 R22.htm IDEA: XBRL DOCUMENT

Debt (Tables)

3 Months Ended

Sep. 30, 2017

Debt Disclosure [Abstract]

Schedule of long term debt

As of	September 30, 2017			June 30, 2017
Term A Loan due June 2022		$	248,438		$	250,000
Capitalized lease obligations			182			—
			248,620			250,000
Unamortized debt issuance costs and debt discount			(1,766)			(1,859)
			246,854			248,141
Less: current maturities			(7,895)			(6,250)
		$	238,959		$	241,891

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

XML 34 R23.htm IDEA: XBRL DOCUMENT

Derivatives (Tables)

3 Months Ended

Sep. 30, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of significant outstanding derivatives employed to manage market risk and designated as cash flow hedges

Instrument

Hedge

Notional
Amount at
September 30,
2017

Fair value as of

Consolidated
Balance Sheet

September 30,
2017

June 30,
2017

Options

Brazilian Real calls

R$19,500

Other current assets

1,781

2,686

Swap

Interest rate swap

$ 150,000

Other assets

283

—

Instrument	Hedge	Gain (loss) recorded in OCI						Gain (loss) recognized in consolidated statements of operations							Consolidated Statement of Operations Line Item Total
Instrument	Hedge	September 30, 2017			September 30, 2016			Consolidated Statement of Operations	September 30, 2017			September 30, 2016			September 30, 2017			September 30, 2016
Options	Brazilian Real calls		$	(905)		$	34	Cost of goods sold		$	186		$	(1,135)		$	130,030		$	126,988
Swap	Interest rate swap		$	283		$	—	Interest expense, net		$	—		$	—		$	3,118		$	3,907

- Definition

Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41641-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41678-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41638-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5580258-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5579245-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5624171-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84234895&loc=SL5579240-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84234895&loc=d3e41620-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

XML 35 R24.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Sep. 30, 2017

Fair Value Disclosures [Abstract]

Schedule of fair value derivatives, assets and liabilities

As of	September 30, 2017									June 30, 2017
	Level 1			Level 2			Level 3			Level 1			Level 2			Level 3
Derivatives asset		$	—		$	1,781		$	—		$	—		$	2,686		$	—
Interest rate swap		$	—		$	283		$	—		$	—		$	—		$	—
Contingent consideration on acquisitions		$	—		$	—		$	(7,827)		$	—		$	—		$	(7,644)

Schedule of changes in the fair value of Level 3 assets

Balance, June 30, 2017	$	(7,644)
Acquisition-related accrued interest		(253)
Payment		70
Balance, September 30, 2017	$	(7,827)

XML 36 R25.htm IDEA: XBRL DOCUMENT

Business Segments (Tables)

3 Months Ended

Sep. 30, 2017

Segment Reporting [Abstract]

Schedule of information regarding reportable segments

	Three Months
For the Periods Ended September 30	2017			2016
Net sales
MFAs and other		$	79,603		$	83,419
Nutritional Specialties			30,777			26,304
Vaccines			18,461			14,778
Animal Health			128,841			124,501
Mineral Nutrition			52,073			51,592
Performance Products			12,498			11,894
Total segments		$	193,412		$	187,987
Depreciation and amortization
Animal Health		$	5,254		$	4,898
Mineral Nutrition			585			542
Performance Products			246			218
Total segments		$	6,085		$	5,658
Adjusted EBITDA
Animal Health		$	33,742		$	32,619
Mineral Nutrition			3,716			3,988
Performance Products			248			742
Total segments		$	37,706		$	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes		$	18,944		$	17,572
Interest expense, net			3,118			3,907
Depreciation and amortization – Total segments			6,085			5,658
Depreciation and amortization – Corporate			559			660
Corporate costs			7,589			7,524
Acquisition-related cost of goods sold			249			—
Acquisition-related accrued compensation			437			420
Acquisition-related transaction costs			400			1,274
Foreign currency (gains) losses, net			325			334
Adjusted EBITDA – Total segments		$	37,706		$	37,349

As of	September 30, 2017			June 30, 2017
Identifiable assets
Animal Health		$	479,075		$	442,521
Mineral Nutrition			60,371			55,184
Performance Products			22,331			23,681
Total segments			561,777			521,386
Corporate			109,334			102,011
Total		$	671,111		$	623,397

XML 37 R26.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Accounting Policies [Abstract]
Net income	$ 15,892	$ 12,177
Weighted average number of shares - basic (in shares)	39,944	39,408
Dilutive effect of stock options	349	498
Weighted average number of shares - diluted (in shares)	40,293	39,906
Net income per share
basic (in dollars per share)	$ 0.40	$ 0.31
diluted (in dollars per share)	$ 0.39	$ 0.31

XML 38 R27.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies and New Accounting Standards (Detail Textuals) $ / shares in Units, $ in Thousands	3 Months Ended
	Sep. 30, 2017 USD ($) $ / shares
Accounting Policies [Abstract]
Cash dividends per share amount (in dollars per share) \| $ / shares	$ 0.10
Cash dividends \| $	$ 3,989

XML 39 R28.htm IDEA: XBRL DOCUMENT

Statements of Operations-Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Interest expense, net
Amortization of debt issuance costs and debt discount	$ 221	$ 253
Acquisition-related accrued interest	253	393
Other	239	81
Interest expense	(3,427)	(4,587)
Interest (income)	(309)	(680)
Interest expense, net	3,118	3,907
Depreciation and amortization
Depreciation of property, plant and equipment	5,183	4,731
Amortization of intangible assets	1,449	1,528
Amortization of other assets	12	59
Depreciation and amortization	6,644	6,318
Term loan
Interest expense, net
Interest expense	2,033	2,905
Revolving credit facility
Interest expense, net
Interest expense	$ 681	$ 955

XML 40 R29.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Inventories
Raw materials	$ 57,719	$ 54,861
Work-in-process	12,014	12,402
Finished goods	101,195	93,970
Inventory, net	$ 170,928	$ 161,233

XML 41 R30.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information (Details 1) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Accrued expenses and other current liabilities
Employee related	$ 21,030	$ 26,553
Commissions and rebates	4,964	6,443
Insurance related	1,522	1,515
Professional fees	3,513	3,823
Income and other taxes	3,631	3,035
Other	16,820	11,283
Accrued expenses and other current liabilities, total	51,480	52,652
Accumulated other comprehensive income (loss)
Derivative instruments	2,064	2,686
Foreign currency translation adjustment	(40,323)	(43,556)
Unrecognized net pension gains (losses)	(17,928)	(18,059)
(Provision) benefit for income taxes on derivative instruments	(1,316)	(1,553)
(Provision) benefit for incomes taxes on long-term intercompany investments	8,166	8,166
(Provision) benefit for income taxes on pension gains (losses)	(3,171)	(3,121)
Accumulated other comprehensive income (loss)	$ (52,508)	$ (55,437)

XML 42 R31.htm IDEA: XBRL DOCUMENT

Balance Sheets-Additional Information (Detail Textuals) $ in Thousands	3 Months Ended
	Sep. 30, 2017 USD ($)
Balance Sheets Additional Information [Abstract]
Equity method investments	$ 3,802
Amount of acquired business approximately	15,000
Payments to acquire business subsequent to reporting date	$ 3,500

XML 43 R32.htm IDEA: XBRL DOCUMENT

Debt - Summary of long-term debt (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Debt Instrument [Line Items]
Long-term debt including current maturities	$ 248,620	$ 250,000
Unamortized debt issuance costs and debt discount	(1,766)	(1,859)
Long-term debt after debt issuance costs	246,854	248,141
Less: current maturities	(7,895)	(6,250)
Long-term debt	238,959	241,891
Capitalized lease obligations
Debt Instrument [Line Items]
Capitalized lease obligations	182	0
Term A Loan due June 2022
Debt Instrument [Line Items]
Term A Loan due June 2022	$ 248,438	$ 250,000

XML 44 R33.htm IDEA: XBRL DOCUMENT

Debt (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended
Debt (Detail Textuals) - USD ($) $ in Thousands	Sep. 30, 2017	Jul. 31, 2017	Jun. 30, 2017
Debt Instrument [Line Items]
Revolving credit facility	$ 85,000		$ 65,000
Interest rate swap
Debt Instrument [Line Items]
Percentage of interest rate		1.8325%
Derivative, notional amount		$ 150,000
Credit agreement (the "Credit Agreement") \| Revolving credit facility (the "Revolver")
Debt Instrument [Line Items]
Maximum borrowing capacity	250,000
Revolving credit facility	85,000
Outstanding letters of credit	4,651
Aggregate available credit facilities	$ 160,349
Weighted-average interest rates	2.98%
Credit agreement (the "Credit Agreement") \| Term A Loan and together with the Revolver, "Credit Facilities"
Debt Instrument [Line Items]
Floor rate	0.00%
Credit agreement (the "Credit Agreement") \| Term A Loan and together with the Revolver, "Credit Facilities" \| LIBOR
Debt Instrument [Line Items]
Interest rate, description	2.00%, 1.75% or 1.50%
Credit agreement (the "Credit Agreement") \| Term A Loan and together with the Revolver, "Credit Facilities" \| Base Rate
Debt Instrument [Line Items]
Interest rate, description	1.00%, 0.75% or 0.50%
Credit agreement (the "Credit Agreement") \| Term A Loan and together with the Revolver, "Credit Facilities" \| Eurodollar
Debt Instrument [Line Items]
Interest rate, description	2.00%, 1.75% or 1.50%
Credit agreement (the "Credit Agreement") \| Term A Loan
Debt Instrument [Line Items]
Aggregate principal amount	$ 250,000
Weighted-average interest rates	3.22%

XML 45 R34.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Relatives of Jack C. Bendheim \| Compensation and benefit for services provided
Related Party Transaction [Line Items]
Aggregate compensation and benefits	$ 720	$ 603

XML 46 R35.htm IDEA: XBRL DOCUMENT

Employee Benefit Plans (Detail Textuals) $ in Thousands	3 Months Ended
Employee Benefit Plans (Detail Textuals) $ in Thousands	Sep. 30, 2016 USD ($)
Compensation and Retirement Disclosure [Abstract]
Pension curtailment gain	$ 6,822

XML 47 R36.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Detail Textuals) $ in Thousands	1 Months Ended	3 Months Ended	12 Months Ended
	Sep. 30, 2012 PRPs	Sep. 30, 2017 USD ($)	Jun. 30, 2017 USD ($)
Commitments And Contingencies [Line Items]
Number of potentially responsible parties \| PRPs	140
Current and long-term liabilities
Commitments And Contingencies [Line Items]
Accrual for environmental loss contingencies payments \| $		$ 6,898	$ 7,211

XML 48 R37.htm IDEA: XBRL DOCUMENT

Derivatives (Details) - Cash flow hedges BRL in Thousands, $ in Thousands	Sep. 30, 2017 USD ($)	Sep. 30, 2017 BRL	Jun. 30, 2017 USD ($)
Options \| Brazilian Real calls
Derivative [Line Items]
Notional amount \| BRL		BRL 19,500
Options \| Brazilian Real calls \| Other current assets
Derivative [Line Items]
Fair value	$ 1,781		$ 2,686
Swap \| Interest rate swap
Derivative [Line Items]
Notional amount	150,000
Swap \| Interest rate swap \| Other assets
Derivative [Line Items]
Fair value	$ 283

XML 49 R38.htm IDEA: XBRL DOCUMENT

Derivatives (Details 1) - USD ($) $ in Thousands	3 Months Ended
Derivatives (Details 1) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016
Derivative [Line Items]
Cost of goods sold	$ 130,030	$ 126,988
Interest expense, net	3,118	3,907
Options \| Cash flow hedges \| Brazilian Real calls \| Cost of goods sold
Derivative [Line Items]
Gain (loss) recognized in consolidated statements of operations	186	(1,135)
Options \| Cash flow hedges \| Brazilian Real calls \| Other comprehensive income (loss)
Derivative [Line Items]
Gain (loss) recorded in OCI	(905)	$ 34
Swap \| Interest rate swap \| Cash flow hedges \| Other comprehensive income (loss)
Derivative [Line Items]
Gain (loss) recorded in OCI	$ 283

XML 50 R39.htm IDEA: XBRL DOCUMENT

Derivatives (Detail Textuals) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
Derivatives (Detail Textuals) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017	Jul. 31, 2017
Options \| Cash flow hedges \| Cost of goods sold
Derivative [Line Items]
Gain (loss) on matured contracts, record to Inventory	$ 1,622		$ 966
Recognize gains in costs of goods sold in next six months	780
Options \| Cash flow hedges \| Cost of goods sold \| Brazilian Real calls
Derivative [Line Items]
Realized losses on hedging derivatives recognized in cost of goods sold	186	$ (1,135)
Options \| Cash flow hedges \| Other comprehensive income (loss)
Derivative [Line Items]
Fair value of foreign currency option that is included accumulated other comprehensive income	$ 1,781
Interest rate swap
Derivative [Line Items]
Percentage of interest rate				1.8325%
Derivative, notional amount				$ 150,000

XML 51 R40.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - Fair values - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivatives asset	$ 1,781	$ 2,686
Interest rate swap	283
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration on acquisitions	$ (7,827)	$ (7,644)

XML 52 R41.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details 1) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Business Combination Contingent Consideration Liability [Roll Forward]
Acquisition-related accrued interest	$ (253)	$ (393)
Fair values \| Level 3
Business Combination Contingent Consideration Liability [Roll Forward]
Balance, June 30, 2017	(7,644)
Acquisition-related accrued interest	(253)
Payment	70
Balance, September 30, 2017	$ (7,827)

XML 53 R42.htm IDEA: XBRL DOCUMENT

Business Segments (Details) - USD ($) $ in Thousands	3 Months Ended
Business Segments (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Sep. 30, 2016	Jun. 30, 2017
Segment Reporting Information [Line Items]
Net sales	$ 193,412	$ 187,987
Depreciation and amortization	6,644	6,318
Adjusted EBITDA - Total segments	37,706	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes	18,944	17,572
Interest expense, net	(3,118)	(3,907)
Depreciation and amortization	6,644	6,318
Acquisition-related accrued compensation	437	420
Foreign currency (gains) losses, net	325	334
Adjusted EBITDA - Total segments	37,706	37,349
Identifiable assets	671,111		$ 623,397
Operating Segments
Segment Reporting Information [Line Items]
Net sales	193,412	187,987
Depreciation and amortization	6,085	5,658
Adjusted EBITDA - Total segments	37,706	37,349
Reconciliation of income before income taxes to Adjusted EBITDA
Income before income taxes	18,944	17,572
Interest expense, net	3,118	3,907
Depreciation and amortization	6,085	5,658
Acquisition-related cost of goods sold	249
Acquisition-related accrued compensation	437	420
Acquisition-related transaction costs	400	1,274
Foreign currency (gains) losses, net	325	334
Adjusted EBITDA - Total segments	37,706	37,349
Identifiable assets	561,777		521,386
Operating Segments \| Animal Health
Segment Reporting Information [Line Items]
Net sales	128,841	124,501
Depreciation and amortization	5,254	4,898
Adjusted EBITDA - Total segments	33,742	32,619
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	5,254	4,898
Adjusted EBITDA - Total segments	33,742	32,619
Identifiable assets	479,075		442,521
Operating Segments \| Mineral Nutrition
Segment Reporting Information [Line Items]
Net sales	52,073	51,592
Depreciation and amortization	585	542
Adjusted EBITDA - Total segments	3,716	3,988
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	585	542
Adjusted EBITDA - Total segments	3,716	3,988
Identifiable assets	60,371		55,184
Operating Segments \| Performance Products
Segment Reporting Information [Line Items]
Net sales	12,498	11,894
Depreciation and amortization	246	218
Adjusted EBITDA - Total segments	248	742
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	246	218
Adjusted EBITDA - Total segments	248	742
Identifiable assets	22,331		23,681
Operating Segments \| MFAs and other \| Animal Health
Segment Reporting Information [Line Items]
Net sales	79,603	83,419
Operating Segments \| Nutritional specialties \| Animal Health
Segment Reporting Information [Line Items]
Net sales	30,777	26,304
Operating Segments \| Vaccines \| Animal Health
Segment Reporting Information [Line Items]
Net sales	18,461	14,778
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization	559	660
Adjusted EBITDA - Total segments	7,589	7,524
Reconciliation of income before income taxes to Adjusted EBITDA
Depreciation and amortization	559	660
Adjusted EBITDA - Total segments	7,589	$ 7,524
Identifiable assets	$ 109,334		$ 102,011

XML 54 R43.htm IDEA: XBRL DOCUMENT

Business Segments (Detail Textuals) - USD ($) $ in Thousands	Sep. 30, 2017	Jun. 30, 2017
Segment Reporting Information [Line Items]
Equity method investments	$ 3,802
Animal Health
Segment Reporting Information [Line Items]
Equity method investments	3,802	$ 3,719
Performance Products
Segment Reporting Information [Line Items]
Equity method investments	$ 559	$ 516

EXCEL 55 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 56 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 57 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 82 176 1 false 35 0 false 6 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.pahc.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Sheet http://www.pahc.com/role/ConsolidatedStatementsOfOperationsUnaudited CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) Statements 2 false false R3.htm 003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) Sheet http://www.pahc.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossUnaudited CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) Statements 3 false false R4.htm 004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) Sheet http://www.pahc.com/role/ConsolidatedBalanceSheetsUnaudited CONSOLIDATED BALANCE SHEETS (unaudited) Statements 4 false false R5.htm 005 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals) (unaudited) Sheet http://www.pahc.com/role/ConsolidatedBalanceSheetsParentheticalsUnaudited CONSOLIDATED BALANCE SHEETS (Parentheticals) (unaudited) Statements 5 false false R6.htm 006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Sheet http://www.pahc.com/role/ConsolidatedStatementsOfCashFlowsUnaudited CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) Statements 6 false false R7.htm 007 - Disclosure - Description of Business Sheet http://www.pahc.com/role/DescriptionOfBusiness Description of Business Notes 7 false false R8.htm 008 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards Sheet http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards Summary of Significant Accounting Policies and New Accounting Standards Notes 8 false false R9.htm 009 - Disclosure - Statements of Operations-Additional Information Sheet http://www.pahc.com/role/StatementsOfOperationsAdditionalInformation Statements of Operations-Additional Information Notes 9 false false R10.htm 010 - Disclosure - Balance Sheets-Additional Information Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformation Balance Sheets-Additional Information Notes 10 false false R11.htm 011 - Disclosure - Debt Sheet http://www.pahc.com/role/Debt Debt Notes 11 false false R12.htm 012 - Disclosure - Related Party Transactions Sheet http://www.pahc.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 013 - Disclosure - Employee Benefit Plans Sheet http://www.pahc.com/role/EmployeeBenefitPlans Employee Benefit Plans Notes 13 false false R14.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.pahc.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 015 - Disclosure - Derivatives Sheet http://www.pahc.com/role/Derivatives Derivatives Notes 15 false false R16.htm 016 - Disclosure - Fair Value Measurements Sheet http://www.pahc.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 017 - Disclosure - Business Segments Sheet http://www.pahc.com/role/BusinessSegments Business Segments Notes 17 false false R18.htm 018 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Policies) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies and New Accounting Standards (Policies) Policies http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 18 false false R19.htm 019 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Tables) Sheet http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables Summary of Significant Accounting Policies and New Accounting Standards (Tables) Tables http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandards 19 false false R20.htm 020 - Disclosure - Statements of Operations-Additional Information (Tables) Sheet http://www.pahc.com/role/StatementsofOperationsAdditionalInformationTables Statements of Operations-Additional Information (Tables) Tables http://www.pahc.com/role/StatementsOfOperationsAdditionalInformation 20 false false R21.htm 021 - Disclosure - Balance Sheets-Additional Information (Tables) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables Balance Sheets-Additional Information (Tables) Tables http://www.pahc.com/role/BalanceSheetsAdditionalInformation 21 false false R22.htm 022 - Disclosure - Debt (Tables) Sheet http://www.pahc.com/role/DebtTables Debt (Tables) Tables http://www.pahc.com/role/Debt 22 false false R23.htm 023 - Disclosure - Derivatives (Tables) Sheet http://www.pahc.com/role/DerivativesTables Derivatives (Tables) Tables http://www.pahc.com/role/Derivatives 23 false false R24.htm 024 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pahc.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pahc.com/role/FairValueMeasurements 24 false false R25.htm 025 - Disclosure - Business Segments (Tables) Sheet http://www.pahc.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.pahc.com/role/BusinessSegments 25 false false R26.htm 026 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Details) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesandNewAccountingStandardsDetails Summary of Significant Accounting Policies and New Accounting Standards (Details) Details http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 26 false false R27.htm 027 - Disclosure - Summary of Significant Accounting Policies and New Accounting Standards (Detail Textuals) Sheet http://www.pahc.com/role/SummaryofSignificantAccountingPoliciesandNewAccountingStandardsDetails3 Summary of Significant Accounting Policies and New Accounting Standards (Detail Textuals) Details http://www.pahc.com/role/SummaryOfSignificantAccountingPoliciesAndNewAccountingStandardsTables 27 false false R28.htm 028 - Disclosure - Statements of Operations-Additional Information (Details) Sheet http://www.pahc.com/role/StatementsOfOperationsAdditionalInformationDetails Statements of Operations-Additional Information (Details) Details http://www.pahc.com/role/StatementsofOperationsAdditionalInformationTables 28 false false R29.htm 029 - Disclosure - Balance Sheets-Additional Information (Details) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetails Balance Sheets-Additional Information (Details) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 29 false false R30.htm 030 - Disclosure - Balance Sheets-Additional Information (Details 1) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetail1 Balance Sheets-Additional Information (Details 1) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 30 false false R31.htm 031 - Disclosure - Balance Sheets-Additional Information (Detail Textuals) Sheet http://www.pahc.com/role/BalanceSheetsAdditionalInformationDetailTextuals Balance Sheets-Additional Information (Detail Textuals) Details http://www.pahc.com/role/BalanceSheetsAdditionalInformationTables 31 false false R32.htm 032 - Disclosure - Debt - Summary of long-term debt (Details) Sheet http://www.pahc.com/role/DebtDetail Debt - Summary of long-term debt (Details) Details 32 false false R33.htm 033 - Disclosure - Debt (Detail Textuals) Sheet http://www.pahc.com/role/DebtDetails1 Debt (Detail Textuals) Details http://www.pahc.com/role/DebtTables 33 false false R34.htm 034 - Disclosure - Related Party Transactions (Detail Textuals) Sheet http://www.pahc.com/role/RelatedPartyTransactionsDetailTextuals Related Party Transactions (Detail Textuals) Details http://www.pahc.com/role/RelatedPartyTransactions 34 false false R35.htm 035 - Disclosure - Employee Benefit Plans (Detail Textuals) Sheet http://www.pahc.com/role/Employeebenefitplansdetailtextuals Employee Benefit Plans (Detail Textuals) Details http://www.pahc.com/role/EmployeeBenefitPlans 35 false false R36.htm 036 - Disclosure - Commitments and Contingencies (Detail Textuals) Sheet http://www.pahc.com/role/CommitmentsAndContingenciesDetailTextuals Commitments and Contingencies (Detail Textuals) Details http://www.pahc.com/role/CommitmentsAndContingencies 36 false false R37.htm 037 - Disclosure - Derivatives (Details) Sheet http://www.pahc.com/role/DerivativesDetails Derivatives (Details) Details http://www.pahc.com/role/DerivativesTables 37 false false R38.htm 038 - Disclosure - Derivatives (Details 1) Sheet http://www.pahc.com/role/DerivativesDetails1 Derivatives (Details 1) Details http://www.pahc.com/role/DerivativesTables 38 false false R39.htm 039 - Disclosure - Derivatives (Detail Textuals) Sheet http://www.pahc.com/role/DerivativesDetailTextuals Derivatives (Detail Textuals) Details http://www.pahc.com/role/DerivativesTables 39 false false R40.htm 040 - Disclosure - Fair Value Measurements (Details) Sheet http://www.pahc.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.pahc.com/role/FairValueMeasurementsTables 40 false false R41.htm 041 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.pahc.com/role/FairValueMeasurementsDetails2 Fair Value Measurements (Details 1) Details http://www.pahc.com/role/FairValueMeasurementsTables 41 false false R42.htm 042 - Disclosure - Business Segments (Details) Sheet http://www.pahc.com/role/BusinessSegmentsDetails Business Segments (Details) Details http://www.pahc.com/role/BusinessSegmentsTables 42 false false R43.htm 043 - Disclosure - Business Segments (Detail Textuals) Sheet http://www.pahc.com/role/Businesssegmentsdetailtextual Business Segments (Detail Textuals) Details http://www.pahc.com/role/BusinessSegmentsTables 43 false false All Reports Book All Reports pahc-20170930.xml pahc-20170930.xsd pahc-20170930_cal.xml pahc-20170930_def.xml pahc-20170930_lab.xml pahc-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 61 0001571049-17-008421-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001571049-17-008421-xbrl.zip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end